BLOOD CANCER UNITED INC: Form 990, tax year 2010
View the entire original 990 at ProPublica ↗
- Organization
- BLOOD CANCER UNITED INC (EIN 13-5644916)
- Tax period
- 2010-07-01 to 2011-06-30
- Filed
- 2012-03-07
- IRS object ID
- 201210679349300911
- Schema version
- 2010v3.7
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule L
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Timestamp | 2012-03-07T11:09:39-06:00 | Timestamp |
| Tax Period End Date | 2011-06-30 | TaxPeriodEndDate |
Preparer Firm PreparerFirm
Preparer Firm Business Name PreparerFirmBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | KPMG LLP | BusinessNameLine1 |
Preparer Firm US Address PreparerFirmUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 345 PARK AVENUE | AddressLine1 |
| City | NEW YORK | City |
| State | NY | State |
| ZIP Code | 101540102 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnType |
| Tax Period Begin Date | 2010-07-01 | TaxPeriodBeginDate |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 135644916 | EIN |
Name Name
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | THE LEUKEMIA & LYMPHOMA | BusinessNameLine1 |
| Business Name Line2 | SOCIETY INC | BusinessNameLine2 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Control | LEUK | NameControl |
| Phone | 9149495213 | Phone |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1311 MAMARONECK AVE | AddressLine1 |
| Address Line2 | ROOM/SUITE 310 | AddressLine2 |
| City | WHITE PLAINS | City |
| State | NY | State |
| ZIP Code | 10605 | ZIPCode |
Officer Officer
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name | JAMES T NANGLE | Name |
| Title | SENIOR VICE PRESIDENT & CFO | Title |
| Phone | 9149495213 | Phone |
| Date Signed | 2012-03-07 | DateSigned |
| Authorize Third Party | true | AuthorizeThirdParty |
Preparer Preparer
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name | KPMG LLP | Name |
| Phone | 2127589700 | Phone |
| Date Prepared | 2012-03-07 | DatePrepared |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax Year | 2010 | TaxYear |
| Build TS | 2016-02-24 21:20:13Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Of Principal Officer Person | JOHN WALTER | NameOfPrincipalOfficerPerson |
Address Principal Officer US AddressPrincipalOfficerUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1311 MAMARONECK AVENUE | AddressLine1 |
| City | WHITE PLAINS | City |
| State | NY | State |
| ZIP Code | 10605 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | 372308194 | GrossReceipts |
| Group Return For Affiliates | false | GroupReturnForAffiliates |
| Organization501c3 | X | Organization501c3 |
| Web Site | WWW.LLS.ORG | WebSite |
| Type Of Organization Corporation | X | TypeOfOrganizationCorporation |
| Year Formation | 1949 | YearFormation |
| State Legal Domicile | NY | StateLegalDomicile |
| Activity Or Mission Description | THE LEUKEMIA & LYMPHOMA SOCIETY'S MISSION IS TO CURE LEUKEMIA, LYMPHOMA, HODGKIN'S DISEASE AND MYELOMA, AND IMPROVE THE QUALITY OF LIFE OF PATIENTS AND THEIR FAMILIES. | ActivityOrMissionDescription |
| Nbr Voting Members Governing Body | 24 | NbrVotingMembersGoverningBody |
| Nbr Independent Voting Members | 23 | NbrIndependentVotingMembers |
| Total Nbr Employees | 1923 | TotalNbrEmployees |
| Total Nbr Volunteers | 3000000 | TotalNbrVolunteers |
| Total Gross UBI | -1562 | TotalGrossUBI |
| Contributions Grants Prior Year | 238276411 | ContributionsGrantsPriorYear |
| Contributions Grants Current Year | 270364921 | ContributionsGrantsCurrentYear |
| Program Service Revenue CY | 0 | ProgramServiceRevenueCY |
| Investment Income Prior Year | 5945189 | InvestmentIncomePriorYear |
| Investment Income Current Year | 10990644 | InvestmentIncomeCurrentYear |
| Other Revenue Prior Year | 2522446 | OtherRevenuePriorYear |
| Other Revenue Current Year | 2476936 | OtherRevenueCurrentYear |
| Total Revenue Prior Year | 246744046 | TotalRevenuePriorYear |
| Total Revenue Current Year | 283832501 | TotalRevenueCurrentYear |
| Grants And Similar Amnts Prior Year | 85577867 | GrantsAndSimilarAmntsPriorYear |
| Grants And Similar Amnts CY | 109608495 | GrantsAndSimilarAmntsCY |
| Benefits Paid To Members CY | 0 | BenefitsPaidToMembersCY |
| Salaries Etc Prior Year | 81834903 | SalariesEtcPriorYear |
| Salaries Etc Current Year | 83658857 | SalariesEtcCurrentYear |
| Total Prof Fundrsng Exp Prior Year | 9299646 | TotalProfFundrsngExpPriorYear |
| Total Prof Fundrsng Exp CY | 9810826 | TotalProfFundrsngExpCY |
| Total Fundrsng Exp Current Year | 45446413 | TotalFundrsngExpCurrentYear |
| Other Expense Prior Year | 73769925 | OtherExpensePriorYear |
| Other Expenses Current Year | 77762946 | OtherExpensesCurrentYear |
| Total Expenses Prior Year | 250482341 | TotalExpensesPriorYear |
| Total Expenses Current Year | 280841124 | TotalExpensesCurrentYear |
| Revenues Less Expenses Prior Year | -3738295 | RevenuesLessExpensesPriorYear |
| Revenues Less Expenses CY | 2991377 | RevenuesLessExpensesCY |
| Total Assets BOY | 221660340 | TotalAssetsBOY |
| Total Assets EOY | 224271874 | TotalAssetsEOY |
| Total Liabilities BOY | 112213271 | TotalLiabilitiesBOY |
| Total Liabilities EOY | 104487981 | TotalLiabilitiesEOY |
| Net Assets Or Fund Balances BOY | 109447069 | NetAssetsOrFundBalancesBOY |
| Net Assets Or Fund Balances EOY | 119783893 | NetAssetsOrFundBalancesEOY |
| Info In Schedule O Part III | X | InfoInScheduleOPartIII |
| Mission Description | THE LEUKEMIA & LYMPHOMA SOCIETY'S MISSION IS TO CURE LEUKEMIA, LYMPHOMA, HODGKIN'S DISEASE AND MYELOMA, AND IMPROVE THE QUALITY OF LIFE OF PATIENTS AND THEIR FAMILIES. | MissionDescription |
| Significant New Program Services | false | SignificantNewProgramServices |
| Significant Change | false | SignificantChange |
| Expense | 68985389 | Expense |
| Grants | 66082184 | Grants |
| Description | A) RESEARCH PROGRAMS: WITH ADVISORY INPUT FROM RECOGNIZED BIOMEDICAL RESEARCH EXPERTS, LLS FUNDS EXEMPLARY PROJECTS ACROSS THE ENTIRE RESEARCH CONTINUUM RELEVANT TO IMPROVED OUTCOMES FOR BLOOD CANCER PATIENTS, FROM BASIC LABORATORY SCIENCE THROUGH CLINICAL TRIALS, AND FROM INVESTIGATOR-INITIATED RESEARCH TO PRIVATE-SECTOR DRUG DEVELOPMENT ALLIANCES. LLS IS DELIBERATE AND PURPOSEFUL IN FINDING AND SUPPORTING RESEARCH THAT IS MOST LIKELY TO HELP PATIENTS AS SOON AS POSSIBLE. (CONTINUED ON SCHEDULE O) TO DATE, LLS HAS INVESTED MORE THAN 814 MILLION IN RESEARCH AIMED AT HELPING ALL BLOOD CANCER PATIENTS LIVE BETTER, LONGER LIVES. WE WILL CONTINUE TO SUPPORT RESEARCH THROUGH OUR INNOVATIVE AND INTEGRATED FUNDING PROGRAMS, UNTIL EVERY PATIENT HAS A SAFE AND EFFECTIVE THERAPY. IN FISCAL YEAR 2011, LLS SUPPORTED RESEARCH IN THE U.S., CANADA, AND 10 OTHER COUNTRIES WITH A TOTAL RESEARCH DISBURSEMENT OF MORE THAN 66 MILLION. OUR CRITICAL ROLE LLS PROGRAMS ACCELERATE RELEVANT RESEARCH OUTCOMES BY: -BUILDING A FOCUSED RESEARCH WORK-FORCE: ASSURING THE NEXT ROUND OF BREAKTHROUGHS REQUIRES THAT YOUNG INVESTIGATORS BE ENCOURAGED TO WORK IN BLOOD CANCER RESEARCH FIELDS. -TURNING DISCOVERIES INTO CLINICAL PROGRESS: BASIC SCIENCE DISCOVERIES MUST BE TRANSLATED INTO NEW, SAFE AND EFFECTIVE TREATMENTS THAT CAN ULTIMATELY PROLONG AND ENHANCE PATIENT LIVES. -SUPPORTING SYNERGY: LARGE GRANTS AND CONTRACTS ENABLE SCIENTISTS IN ACADEMIA AND THE PRIVATE-SECTOR TO COLLABORATE, COMBINING RESOURCES AND EXPERTISE TO PRODUCE MORE AND FASTER ADVANCES. -FILLING A VOID: PROMISING RESEARCH PROJECTS THAT ARE HIGH-RISK AND/OR ADDRESS RARE CANCERS ARE LESS LIKELY TO BE FUNDED BY THE GOVERNMENT OR BY FOR-PROFIT COMPANIES, BUT MAY PROVIDE IMPORTANT ADVANCES. -INCREASING ACCESS TO CLINICAL TRIALS: PARTNERING WITH LEADING CLINICAL TRIAL CENTERS CAN ACCELERATE THE CLINICAL TESTING OF NEW BLOOD CANCER THERAPIES THAT ARE OFTEN A PATIENT'S BEST CHANCE FOR CURE. LLS RESEARCH PROGRAMS ARE BASED ON THE BELIEF THAT SCIENTIFICALLY SOUND APPROACHES TOWARD CURES FOR, OR CONTROL OF, BLOOD CANCERS SHOULD BE SUPPORTED WORLDWIDE.TWO MAJOR INTEGRATED RESEARCH FUNDING PROGRAMS THE RESEARCH GRANT PROGRAM AND THE THERAPY ACCELERATION PROGRAM HAVE ADVISORY INPUT FROM WORLD RENOWNED BIOMEDICAL RESEARCH EXPERTS. TOGETHER THESE PROGRAMS: -SUPPORT THE ENTIRE RESEARCH CONTINUUM NEEDED TO IMPROVE OUTCOMES FOR BLOOD CANCER PATIENTS FROM BASIC LABORATORY SCIENCE TO CLINICAL TRIALS OF NEW AGENTS AND FROM INVESTIGATOR INITIATED RESEARCH TO MULTIDISCIPLINARY ACADEMIC COLLABORATIONS AND PRIVATE SECTOR DRUG DEVELOPMENT ALLIANCES. -ARE AIMED AT THE EFFECTIVE DISCOVERY AND DEVELOPMENT OF NEW AND BETTER THERAPIES FOR PEOPLE WITH BLOOD CANCER, AND, THROUGH A RESEARCH INITIATIVE LAUNCHED IN 2009, SUPPORT THE DEVELOPMENT OF MEASURES TO PREVENT OR SIGNIFICANTLY REDUCE POTENTIAL LONG-TERM AND LATE TOXICITIES OF TODAY'S CURATIVE THERAPIES. RESEARCH GRANT PROGRAM THE RESEARCH GRANT PROGRAM PROVIDES GRANT FUNDING TO SUPPORT SCIENTIFIC STUDIES AT ACADEMIC CENTERS IN THE UNITED STATES AND THROUGHOUT THE WORLD, THROUGH THREE GRANT MECHANISMS: 1. THE CAREER DEVELOPMENT PROGRAM (CDP) PROVIDES STIPENDS TO INVESTIGATORS OF EXCEPTIONAL PROMISE IN THE EARLY STAGES OF THEIR CAREERS, HELPING THEM TO DEVOTE THEIR CAREERS TO LEUKEMIA, LYMPHOMA AND/OR MYELOMA RESEARCH. THIS PROGRAM IS STRATIFIED INTO TWO SEPARATELY REVIEWED PROGRAMS IN BASIC OR CLINICAL RESEARCH: -BASIC RESEARCH "SCHOLARS ARE AWARDED UP TO 110,000 A YEAR FOR A TOTAL OF UP TO 550,000 OVER FIVE YEARS. "SPECIAL FELLOWS ARE AWARDED UP TO 65,000 A YEAR FOR A TOTAL OF UP TO 195,000 OVER THREE YEARS. "FELLOWS ARE AWARDED UP TO 55,000 A YEAR FOR A TOTAL OF UP TO 165,000 OVER THREE YEARS. -CLINICAL RESEARCH "SCHOLARS IN CLINICAL RESEARCH ARE AWARDED UP TO 110,000 A YEAR FOR A TOTAL OF UP TO 550,000 OVER FIVE YEARS. "SPECIAL FELLOWS IN CLINICAL RESEARCH ARE AWARDED UP TO 65,000 A YEAR FOR A TOTAL OF UP TO 195,000 OVER THREE YEARS. 2. THE TRANSLATIONAL RESEARCH PROGRAM (TRP) SUPPORTS OUTSTANDING INVESTIGATIONS DEEMED BY OUR EXPERT ADVISORS MOST LIKELY TO TRANSLATE BASIC BIOMEDICAL DISCOVERIES INTO NEW, SAFE AND EFFECTIVE TREATMENTS, ULTIMATELY PROLONGING AND ENHANCING PATIENTS' LIVES. TRANSLATIONAL RESEARCH AWARDS ARE MADE FOR AN INITIAL THREE-YEAR PERIOD. AWARDS UP TO 200,000 PER YEAR FOR THREE YEARS, FOR A TOTAL OF UP TO 600,000, ARE GRANTED EACH YEAR. FUNDING FOR TWO ADDITIONAL YEARS MAY BE PROVIDED FOR HIGHLY PROMISING PROJECTS THAT ARE ENTERING PHASE 1 CLINICAL TRIALS. THUS, RESEARCH REACHING A CLINICAL TRIAL CAN RECEIVE UP TO 1 MILLION OVER FIVE YEARS TO FACILITATE NEW DRUG DISCOVERY OR ADVANCES IN DIAGNOSIS OR PREVENTION. IN 2011, LLS ACTIVELY REQUESTED PROPOSALS TO HELP STIMULATE MORE ACADEMIC RESEARCH IN THREE UNDERDEVELOPED YET IMPORTANT AREAS OF RESEARCH. THE RESEARCH TOPICS EMPHASIZED WERE: 1) THE MALIGNANT STEM CELL IN ACUTE MYELOGENOUS LEUKEMIA AND MYELODYSPLASTIC SYNDROMES; 2) NON-CUTANEOUS T-CELL LEUKEMIAS AND LYMPHOMAS AND 3) HIGH RISK MYELOMA CASES. IN ADDITION, A REQUEST FOR RESEARCH FOCUSED ON LONG-TERM AND LATE EFFECTS OF BLOOD CANCER THERAPIES WAS EXTENDED INTO A SECOND YEAR. PROGRESS IN THESE RESEARCH AREAS IS DEEMED LIKELY TO IMPROVE OUTCOMES FOR PATIENTS WITH PARTICULARLY URGENT NEEDS. 3. THE MARSHALL A. LICHTMAN SPECIALIZED CENTER OF RESEARCH PROGRAM (SCOR) ENCOURAGES MULTIDISCIPLINARY RESEARCH BY LEADING-EDGE ACADEMIC INVESTIGATORS IN TEAMS OF AT LEAST THREE RESEARCH GROUPS THAT INTERACT TO FOSTER ADVANCES IN THE DIAGNOSIS, TREATMENT AND/OR PREVENTION OF BLOOD CANCERS. EACH SCOR GROUP IS FUNDED UP TO 1.25 MILLION PER YEAR OVER A FIVE-YEAR PERIOD, WITH A TOTAL AMOUNT OF UP TO 6.25 MILLION. AWARDS GO TO THOSE GROUPS THAT BEST DEMONSTRATE SYNERGISTIC EXPERTISE IN COMPLEMENTARY AREAS . THE PARTICIPATING SCIENTISTS MAY BE AT DIFFERENT INSTITUTIONS OR FROM ANY COUNTRY. THE GRANT REVIEW PROCESS FOR THE RESEARCH GRANT PROGRAM. SCIENTISTS AND PHYSICIAN SCIENTISTS WHO ARE EXPERTS IN THE FIELD OF BLOOD CANCER RESEARCH VOLUNTEER THEIR SERVICE TO CONSTITUTE PEER-REVIEW SUBCOMMITTEES FOR BASIC RESEARCH CDP, CLINICAL RESEARCH CDP, TRP AND SCOR. THESE COMMITTEES EVALUATE ALL GRANT APPLICATIONS IN THOSE PROGRAMS AND SELECT THOSE APPLICANTS WITH THE MOST INNOVATIVE AND IMPORTANT PROJECTS TO ADVANCE THE MISSION OF LLS. GUIDELINES, INSTRUCTIONS AND APPLICATIONS FOR THE THREE LLS RESEARCH PROGRAMS MAY BE OBTAINED BY VISITING WWW.LLS.ORG OR BY EMAILING RESEARCHPROGRAMS@LLS.ORG. THERAPY ACCELERATION PROGRAM THE THERAPY ACCELERATION PROGRAM (TAP) IS A STRATEGIC LLS INITIATIVE LAUNCHED IN 2007 WITH 4 MILLION IN SEED FUNDING. THE PROGRAM ACCELERATES NEW AND POTENTIALLY BETTER TREATMENTS AND CLINICAL TESTS INTO PRECLINICAL DEVELOPMENT AND CLINICAL TRIALS. WORKING IN CONCERT WITH ACADEMIC INVESTIGATORS, MEDICAL CENTERS AND COMPANIES, TAP IS FURTHER BRIDGING THE GAP BETWEEN DISCOVERY AND HUMAN APPLICATIONS TO INCREASE THE LIKELIHOOD THAT NOVEL, POSSIBLY BREAKTHROUGH, TREATMENTS WILL BE MADE AVAILABLE TO PATIENTS AS SOON AS POSSIBLE. TAP ENCOMPASSES THREE INNOVATIVE EFFORTS: 1. THE ACADEMIC CONCIERGE DIVISION IDENTIFIES CURRENT LLS FUNDED RESEARCH WITH THE GREATEST CLINICAL PROMISE AND PROVIDES THE FUNDING AND SUPPORT NEEDED TO ADVANCE SELECTED PROJECTS TO THE PRODUCT STAGE. 2.THE CLINICAL TRIALS DIVISION PARTNERS LLS WITH ONE OF THE COUNTRY'S LEADING CLINICAL TRIAL CENTERS TO ACCELERATE THE TESTING OF NEW BLOOD CANCER THERAPIES IN CLINICAL TRIALS. 3. THE BIOTECHNOLOGY ACCELERATOR DIVISION ALLIES LLS WITH COMPANIES TO COMBINE SCIENTIFIC AND FINANCIAL RESOURCES AND ACCELERATE THE DEVELOPMENT OF POTENTIAL THERAPIES THAT OTHERWISE WOULD NOT BE PRIORITIZED BY THE COMPANY. THE TAP PROJECT REVIEW PROCESS INVOLVES DUE DILIGENCE BY AN LLS STAFF TEAM OF DRUG DEVELOPMENT SPECIALISTS IN CONCERT WITH A VOLUNTEER PANEL OF LEADING BIOTECHNOLOGY AND PHARMACEUTICAL COMPANY EXECUTIVES AND INTELLECTUAL PROPERTY AND BUSINESS DEVELOPMENT EXPERTS. THE LEARNING COLLABORATIVE IN 2011, LLS BEGAN A UNIQUE COLLABORATION WITH THE UNIVERSITY OF KANSAS CANCER CENTER AND THE NATIONAL INSTITUTES OF HEALTH TO ACCELERATE THE DEVELOPMENT OF POTENTIAL THERAPIES FOR RARE BLOOD CANCERS. THIS COLLABORATION, KNOWN AS THE LEARNING COLLABORATIVE, BRINGS TOGETHER PROVEN EXPERTISE IN BLOOD CANCER RESEARCH AS WELL AS DRUG DISCOVERY AND DEVELOPMENT TO RAPIDLY ADVANCE PROMISING NEW THERAPIES FROM THE BENCH TO THE BEDSIDE. IF SUCCESSFUL, THE LEARNING COLLABORATIVE'S NOVEL MODEL WILL DEMONSTRATE THAT GOVERNMENT, ACADEMIA, DISEASE PHILANTHROPY AND INDUSTRY CAN SUCCESSFULLY PARTNER TO SAFELY AND EFFICIENTLY ADVANCE NEW OR REPURPOSED DRUG THERAPIES TO PATIENTS. | Description |
Activity2 Activity2
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 99695257 | Expense |
| Grants | 43526311 | Grants |
| Description | B) PATIENT & COMMUNITY SERVICES : AN ESTIMATED 1,012,533 PEOPLE ACROSS THE UNITED STATES (US) CURRENTLY BATTLE LEUKEMIA, LYMPHOMA AND MYELOMA. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) OFFERS THE MOST COMPREHENSIVE ARRAY OF SERVICES TO BLOOD CANCER PATIENTS AND THEIR FAMILIES. LAST YEAR ALONE, LLS MADE 7.1 MILLION CONTACTS WITH PATIENTS, CAREGIVERS, HEALTHCARE PROFESSIONALS AND THE PUBLIC. (CONTINUED ON SCHEDULE O) CHAPTER-BASED PROGRAMS: EACH LLS CHAPTER IS STAFFED WITH A PATIENT SERVICES MANAGER WHO OVERSEES THE CHAPTER'S SERVICES TO PATIENTS AND THEIR FAMILIES. PATIENT SERVICES MANAGERS ARE HEALTHCARE PROFESSIONALS, OFTEN WITH A BACKGROUND IN ONCOLOGY NURSING OR SOCIAL WORK. COMMUNITY BASED EDUCATION, INCLUDING THE FOLLOWING FOUR PROGRAMS, ARE OFFERED THROUGH ALL THE CHAPTERS - 38,959 PATIENT AND CAREGIVER PARTICIPANTS IN 2011 - 12,236 HEALTHCARE PROFESSIONAL PARTICIPANTS IN 2011 IMPROVING TREATMENTS FOR BLOOD CANCERS: WHAT YOU NEED TO KNOW TO MAKE INFORMED DECISIONS THIS PROGRAM DETAILS NEW TREATMENT DEVELOPMENT, TREATMENT DECISIONS (STANDARD OF CARE VERSUS CLINICAL TRIALS) AND HOW PATIENTS CAN COMMUNICATE MORE EFFECTIVELY WITH THEIR MEDICAL TEAMS. MYELOMA UPDATE: DIAGNOSIS, TREATMENT AND SIDE EFFECTS MANAGEMENT THIS PROGRAM PROVIDES PATIENTS, FAMILY MEMBERS AND CAREGIVERS WITH THE LATEST INFORMATION ON MYELOMA AND MYELOMA THERAPY, INCLUDING A QUESTION AND ANSWER SESSION WITH A MEDICAL EXPERT IN THEIR COMMUNITY. GETTING THE BEST CANCER CARE AT AGE 55 AND OLDER THIS EDUCATION PROGRAM PRESENTS AN OVERVIEW OF THE MANY FACTORS, NOT AGE ALONE, THAT HEALTHCARE PROFESSIONALS SHOULD ASSESS TO DETERMINE AN APPROPRIATE CANCER TREATMENT PLAN FOR AN OLDER ADULT. WELCOME BACK: WORKING TOGETHER TO SUPPORT THE CANCER SURVIVOR AT SCHOOL THIS EDUCATION PROGRAM DISCUSSES POSSIBLE EMOTIONAL AND COGNITIVE SHORT- AND LONG-TERM EFFECTS THAT CHILDREN MAY EXPERIENCE AFTER TREATMENT, AND OFFERS NUMEROUS RESOURCES THAT CAN IMPROVE THE TRANSITION OF CANCER SURVIVORS FROM CLINIC TO CLASSROOM. SUPPORT SERVICES: FAMILY SUPPORT GROUPS LLS HAS DEVELOPED 452 FAMILY SUPPORT GROUPS AT CHAPTERS THROUGHOUT THE US AND CANADA. LLS ALSO HAS 825 VOLUNTEER SUPPORT GROUP FACILITATORS WITH BACKGROUNDS IN ONCOLOGY NURSING OR SOCIAL WORK. GROUPS ARE GUIDED BY TWO VOLUNTEER ONCOLOGY HEALTH PROFESSIONALS, AND PROVIDE INFORMATION AND SUPPORT AND ENCOURAGE GREATER COMMUNICATION AMONG PATIENTS, FAMILIES, FRIENDS AND HEALTH CARE PROFESSIONALS. - 13,108 PARTICIPANTS IN FAMILY SUPPORT GROUPS IN 2011 PATTI ROBINSON KAUFMANN FIRST CONNECTION PROGRAM FIRST CONNECTION IS A PROGRAM THAT LINKS NEWLY DIAGNOSED PATIENTS TO A PEER VOLUNTEER WHO HAS EXPERIENCED A SIMILAR DIAGNOSIS. A TRAINED PATIENT-VOLUNTEER CURRENTLY IN REMISSION CONTACTS THE NEW PATIENT TO SHARE INFORMATION AND SUPPORT. THIS PROGRAM IS AVAILABLE THROUGH LLS CHAPTERS. - 5,094 FIRST CONNECTIONS IN 2011 PATIENT FINANCIAL AID PROGRAM FOR MORE THAN 45 YEARS, LLS HAS HELPED PATIENTS DEMONSTRATING SIGNIFICANT NEED TO OBTAIN FINANCIAL ASSISTANCE TO COVER A PORTION OF THEIR TREATMENT COSTS. THE LLS PATIENT FINANCIAL AID PROGRAM PROVIDES A LIMITED AMOUNT OF FINANCIAL ASSISTANCE TO HELP PATIENTS WITH SIGNIFICANT FINANCIAL NEED AND WHO ARE UNDER A DOCTOR'S CARE FOR A CONFIRMED BLOOD CANCER DIAGNOSIS. PATIENT FINANCIAL AID FUNDS ARE SUBJECT TO AVAILABILITY. - 37,210 PATIENTS RECEIVED FINANCIAL AID IN 2011 CO-PAY ASSISTANCE PROGRAM THIS ASSISTANCE PROGRAM HELPS PATIENTS WITH MANY KINDS OF BLOOD CANCERS MEET THEIR HEALTH INSURANCE OR MEDICARE PLAN PART B OR D PREMIUMS OR CO-PAYMENT OBLIGATIONS RELATED TO TREATING THEIR CANCER. PATIENTS WITH PRESCRIPTION DRUG COVERAGE, MEDICARE BENEFICIARIES UNDER MEDICARE PART B AND/OR MEDICARE PART D, MEDICARE SUPPLEMENTARY HEALTH INSURANCE OR MEDICARE ADVANTAGE SHOULD CHECK WITH LLS TO SEE IF THEY MEET ELIGIBILITY REQUIREMENTS TO RECEIVE FINANCIAL SUPPORT. CO-PAY ASSISTANCE IS SUBJECT TO FUND AVAILABILITY BY SPECIFIC BLOOD CANCER DIAGNOSIS. FOR MORE INFORMATION CALL, (877) LLS-COPAY (877) 557-2672 OR VISIT WWW.LLS.ORG/COPAY. - 13,130 PATIENTS RECEIVED LLS CO-PAY ASSISTANCE IN 2011 THE TRISH GREENE BACK TO SCHOOL PROGRAM FOR CHILDREN WITH CANCER THIS PROGRAM IS DESIGNED TO INCREASE COMMUNICATION AMONG HEALTH CARE PROFESSIONALS, PARENTS, PATIENTS AND SCHOOL PERSONNEL TO ASSURE YOUNGSTERS A SMOOTH TRANSITION FROM ACTIVE TREATMENT BACK TO SCHOOL. PRINTED LITERATURE, VIDEOS AND OTHER MATERIALS TO AID THE PROCESS ARE AVAILABLE THROUGH ALL LOCAL CHAPTERS, INCLUDING: "WELCOME BACK: WORKING TOGETHER TO SUPPORT THE CANCER SURVIVOR AT SCHOOL". THIS EDUCATION PROGRAM DISCUSSES POSSIBLE EMOTIONAL AND COGNITIVE SHORT- AND LONG-TERM EFFECTS THAT CHILDREN MAY EXPERIENCE AFTER TREATMENT, AND OFFERS NUMEROUS RESOURCES THAT CAN IMPROVE THE TRANSITION OF CANCER SURVIVORS FROM CLINIC TO CLASSROOM. - 3,219 SCHOOL PERSONNEL, HEALTHCARE PROFESSIONALS AND PARENTS PARTICIPATED IN THE 74 WELCOME BACK PROGRAMS ACROSS THE US AND CANADA "LEARNING AND LIVING WITH CANCER: ADVOCATING FOR YOUR CHILD'S EDUCATIONAL NEEDS" THIS BOOKLET OFFERS PARENTS INFORMATION ON THE LEARNING CHALLENGES CHILDREN MAY FACE DURING AND AFTER CANCER TREATMENT, LAWS THAT PROTECT THE EDUCATIONAL NEEDS OF CHILDREN WITH CANCER AND SPECIFIC WAYS THAT SCHOOLS CAN HELP MEET A CHILD'S EDUCATIONAL NEEDS | Description |
Activity3 Activity3
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 38403332 | Expense |
| Description | C) PUBLIC HEALTH EDUCATION: INFORMATION AND EDUCATION NATIONAL PROGRAMS: INFORMATION RESOURCE CENTER LLS INFORMATION SPECIALISTS ARE MASTER'S LEVEL ONCOLOGY SOCIAL WORKERS, NURSES AND HEALTH EDUCATORS WHO PROVIDE HELP WITH DISEASE, TREATMENT AND CLINICAL TRIALS INFORMATION AND SUPPORT. (CONTINUED ON SCHEDULE O) PATIENTS, FAMILIES AND HEALTHCARE PROFESSIONALS MAY SPEAK TO AN INFORMATION SPECIALIST AT (800) 955-4572 MONDAY THROUGH FRIDAY, 9 A.M. TO 6 P.M., ET OR EMAIL INFOCENTER@LLS.ORG. - 69,777 INQUIRIES IN 2011 - TRANSLATION SERVICES AVAILABLE IN MORE THAN 165 LANGUAGES ONLINE ENGAGEMENT THE LLS WEBSITE SERVES A WIDE VARIETY OF EDUCATION AND INFORMATION NEEDS. USERS CAN PERSONALIZE THEIR LLS WEB PAGES TO KEEP CURRENT WITH DISEASE SPECIFIC UPDATES AND LOCAL CHAPTER EDUCATION, SUPPORT AND EVENT ACTIVITIES. THE SITE FEATURES A COMPREHENSIVE OVERVIEW OF LLS PROGRAMS AND SERVICES, FAMILY SUPPORT GROUP LOCATIONS, INFORMATION ABOUT OUR PEER-TO-PEER PATTI ROBINSON KAUFMANN FIRST CONNECTION PROGRAM, AND OTHER PROGRAMS. PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS CAN INTERACT WITH LLS IN CONVENIENT AND PERSONAL WAYS THROUGH SOCIAL NETWORKING, PODCASTS AND ENEWSLETTERS. - 5.8 MILLION UNIQUE VISITS TO WWW.LLS.ORG IN 2011, WITH MORE THAN 7.5 MILLION PAGE VIEWS - 409,799 UNIQUE VISITS TO OUR BLOOD CANCER DISCUSSION BOARDS - 157,877 TELECONFERENCE DOWNLOADS - 208,822 SUBSCRIBERS TO OUR DISEASE SPECIFIC ENEWSLETTERS, WHICH ARE ISSUED ON A MONTHLY BASIS - 116,797 FOLLOWERS OF OUR PATIENT AND CAREGIVER COMMUNITY ONLINE TELEPHONE & WEB EDUCATION PROGRAMS LLS SPONSORS TELEPHONE AND WEB EDUCATION PROGRAMS FOR PATIENTS, CAREGIVERS, SURVIVORS AND HEALTHCARE PROFESSIONALS ABOUT LEUKEMIA, LYMPHOMA, MYELOMA AND MYELODYSPLASTIC SYNDROMES. UPCOMING PROGRAMS ARE POSTED AT WWW.LLS.ORG/PROGRAMS AND ARCHIVES OF PAST PROGRAMS ARE AVAILABLE AT WWW.LLS.ORG/PASTPROGRAMS. - 251,077 TELEPHONE AND WEB-BASED PROGRAM PARTICIPANTS IN 2011 EDUCATION MATERIALS AN EXTENSIVE CATALOG OF EDUCATION MATERIALS IS OFFERED FREE-OF-CHARGE TO PATIENTS AND HEALTHCARE PROFESSIONALS. EACH YEAR, LLS DISTRIBUTES BOOKLETS, BROCHURES, FACT SHEETS, EDUCATION PROGRAM TRANSCRIPTS AND DVDS THROUGH THE INFORMATION RESOURCE CENTER AND LOCAL LLS CHAPTERS. - 1,061,018 PRINTED BOOKLETS, BROCHURES, FACT SHEETS, EDUCATION PROGRAM TRANSCRIPTS AND DVDS DISTRIBUTED IN 2011 MANY MATERIALS ARE ALSO AVAILABLE TO VIEW AND DOWNLOAD AT WWW.LLS.ORG/RESOURCECENTER. DOWNLOADABLE MATERIALS ARE AVAILABLE IN ENGLISH, SPANISH AND FRENCH. | Description |
Activity Other ActivityOther
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 7774360 | Expense |
| Description | D) PROFESSIONAL EDUCATION: LLS SERVES THE EDUCATIONAL NEEDS OF THE MEDICAL AND RESEARCH COMMUNITY THROUGH A NUMBER OF PROFESSIONAL EDUCATION SYMPOSIA OFFERED THROUGHOUT THE YEAR. THE EDUCATIONAL PROGRAM OFFERS VARYING FORMATS TO FACILITATE THE EXCHANGE OF INFORMATION AND IDEAS ON THE NEWEST DEVELOPMENTS IN CANCER RESEARCH AND TREATMENT. | Description |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Other Program Service Exp | 7774360 | TotalOfOtherProgramServiceExp |
| Total Program Service Expense | 214858338 | TotalProgramServiceExpense |
| Described In501 C3 | true | DescribedIn501C3 |
| Schedule B Required | true | ScheduleBRequired |
| Political Activities | false | PoliticalActivities |
| Lobbying Activities | true | LobbyingActivities |
| Subject To Proxy Tax | false | SubjectToProxyTax |
| Donor Advised Funds | false | DonorAdvisedFunds |
| Conservation Easements | false | ConservationEasements |
| Collections Of Art | true | CollectionsOfArt |
| Credit Counseling | false | CreditCounseling |
| Term Or Permanent Endowments | true | TermOrPermanentEndowments |
| Report Land Bldg Equip | true | ReportLandBldgEquip |
| Report Invest Oth Securities | true | ReportInvestOthSecurities |
| Report Prog Rel Invest | false | ReportProgRelInvest |
| Report Other Assets | false | ReportOtherAssets |
| Report Other Liabilities | false | ReportOtherLiabilities |
| Report Fin48 Footnote | true | ReportFin48Footnote |
| Independent Audit Financial Stmt | false | IndependentAuditFinancialStmt |
| Consolidated Audit Financial Stmt | true | ConsolidatedAuditFinancialStmt |
| School | false | School |
| Foreign Office | true | ForeignOffice |
| Foreign Activities | true | ForeignActivities |
| More Than5000 K To Organizations | true | MoreThan5000KToOrganizations |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividuals |
| Professional Fundraising | true | ProfessionalFundraising |
| Fundraising Activities | true | FundraisingActivities |
| Gaming | true | Gaming |
| Hospital | false | Hospital |
| Grants To Organizations | true | GrantsToOrganizations |
| Grants To Individuals | true | GrantsToIndividuals |
| Schedule J Required | true | ScheduleJRequired |
| Tax Exempt Bonds | false | TaxExemptBonds |
| Excess Benefit Transaction | false | ExcessBenefitTransaction |
| Prior Excess Benefit Transaction | false | PriorExcessBenefitTransaction |
| Loan To Officer Or DQP | false | LoanToOfficerOrDQP |
| Grant To Related Person | false | GrantToRelatedPerson |
| Bsnss Rltnshp With Organization | true | BsnssRltnshpWithOrganization |
| Bsnss Rltnshp Thru Family Member | false | BsnssRltnshpThruFamilyMember |
| Officer Entity With Bsnss Rltnshp | true | OfficerEntityWithBsnssRltnshp |
| Deductible Non Cash Contributions | true | DeductibleNonCashContributions |
| Deductible Contributions Of Art | false | DeductibleContributionsOfArt |
| Terminated | false | Terminated |
| Partial Liquidation | false | PartialLiquidation |
| Disregarded Entity | false | DisregardedEntity |
| Related Entity | true | RelatedEntity |
| Related Org Controlled Entity | true | RelatedOrgControlledEntity |
| Transaction Related Entity | true | TransactionRelatedEntity |
| Transfers To Exempt Non Chrtbl Org | false | TransfersToExemptNonChrtblOrg |
| Activities Conducted Partnership | false | ActivitiesConductedPartnership |
| Schedule O Required | true | ScheduleORequired |
| Number Forms Transmitted With1096 | 1262 | NumberFormsTransmittedWith1096 |
| Number W2 G Included | 40 | NumberW2GIncluded |
| Compliance With Backup Witholding | true | ComplianceWithBackupWitholding |
| Number Of Employees | 1923 | NumberOfEmployees |
| Employment Tax Returns Filed | true | EmploymentTaxReturnsFiled |
| Unrelated Business Income | true | UnrelatedBusinessIncome |
| Form990-T Filed | true | Form990-TFiled |
| Foreign Financial Account | true | ForeignFinancialAccount |
| Name Of Foreign Country | CA | NameOfForeignCountry |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTrans |
| Taxable Party Notification | false | TaxablePartyNotification |
| Non Deductible Contributions | true | NonDeductibleContributions |
| Non Deductible Disclosure | true | NonDeductibleDisclosure |
| Quid Pro Quo Contributions | true | QuidProQuoContributions |
| Quid Pro Quo Disclosure | true | QuidProQuoDisclosure |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOf |
| Funds To Pay Premiums | false | FundsToPayPremiums |
| Premiums Paid | false | PremiumsPaid |
| Indoor Tanning Services | false | IndoorTanningServices |
| Info In Schedule O Part VI | X | InfoInScheduleOPartVI |
| Nbr Voting Governing Body Members | 24 | NbrVotingGoverningBodyMembers |
| Number Independent Voting Members | 23 | NumberIndependentVotingMembers |
| Family Or Business Relationship | false | FamilyOrBusinessRelationship |
| Delegation Of Management Duties | false | DelegationOfManagementDuties |
| Changes To Organizing Docs | false | ChangesToOrganizingDocs |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuse |
| Members Or Stockholders | true | MembersOrStockholders |
| Election Of Board Members | true | ElectionOfBoardMembers |
| Decisions Subject To Approval | true | DecisionsSubjectToApproval |
| Minutes Of Governing Body | true | MinutesOfGoverningBody |
| Minutes Of Committees | true | MinutesOfCommittees |
| Officer Mailing Address | false | OfficerMailingAddress |
| Local Chapters | true | LocalChapters |
| Policies Reference Chapters | true | PoliciesReferenceChapters |
| Form990 Provided To Governing Body | true | Form990ProvidedToGoverningBody |
| Conflict Of Interest Policy | true | ConflictOfInterestPolicy |
| Annual Disclosure Covered Persons | true | AnnualDisclosureCoveredPersons |
| Regular Monitoring Enforcement | true | RegularMonitoringEnforcement |
| Whistleblower Policy | true | WhistleblowerPolicy |
| Document Retention Policy | true | DocumentRetentionPolicy |
| Compensation Process CEO | true | CompensationProcessCEO |
| Compensation Process Other | true | CompensationProcessOther |
| Investment In Joint Venture | false | InvestmentInJointVenture |
| States Where Copy Of Return Is Filed | AK | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | AR | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | AZ | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | CA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | CT | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | DE | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | FL | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | GA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | IL | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | IN | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | KS | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | KY | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | LA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MD | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | ME | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MI | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MN | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MO | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MS | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NH | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NJ | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NM | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NV | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NY | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | OH | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | OK | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | OR | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | PA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | PR | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | RI | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | SC | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | TN | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | UT | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | VA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | WA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | WI | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | WV | StatesWhereCopyOfReturnIsFiled |
| Own Website | X | OwnWebsite |
| Upon Request | X | UponRequest |
The Books Are In Care Of TheBooksAreInCareOf
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Person | JAMES T NANGLE | NamePerson |
| Telephone Number | 9149495213 | TelephoneNumber |
Address US AddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1311 MAMARONECK AVENUE | AddressLine1 |
| City | WHITE PLAINS | City |
| State | NY | State |
| ZIP Code | 10605 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part VII | X | InfoInScheduleOPartVII |
Form990 Part VII Section A Form990PartVIISectionA (32 entries)
| TitleTitle | Average Hours Per WeekAverageHoursPerWeek | Individual Trustee Or DirectorIndividualTrusteeOrDirector | Reportable Comp From OrganizationReportableCompFromOrganization | Reportable Comp From Related OrgsReportableCompFromRelatedOrgs | Other CompensationOtherCompensation | OfficerOfficer | Highest Compensated EmployeeHighestCompensatedEmployee |
|---|---|---|---|---|---|---|---|
| JAMES A BECK | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| JORGE L BENITEZ | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| ELIZABETH J CLARK | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| JORGE CORTES MD | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| JAMES H DAVISPHD | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| THOMAS L FITZPATRICK | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| ALAN M GEWIRTZMD | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| D GARY GILLILANDMD PHD | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| STEVEN HOOKER | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| RAANAN HOROWITZ | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| JOHN M KAMINS | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| ARMAND KEATINGMD | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| JOSEPH B KELLEY | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| MATTHEW WINTER | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| RODMAN N MYERS | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| DEREK RAGHAVANMDPHDFACP | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| KENNETH M SCHWARTZ | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| NORBERT J SIEBER | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| JAY L SILVER | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| WILLIAM M WARD JR | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| LOUISE E WARNER | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| MICHELE C WONG | |||||||
| BOD MEMBER | 2.00 | X | 0 | 0 | 0 | ||
| JOHN WALTER | |||||||
| PRESIDENT & | 45.00 | 519525 | 0 | 52493 | X | ||
| JAMES T NANGLE | |||||||
| SVP&CFO | 45.00 | 232816 | 0 | 43907 | X | ||
| SCOTT A CARROLL | |||||||
| CHAIR | 2.00 | 0 | 0 | 0 | X | ||
| TIMOTHY DURST | |||||||
| VICE CHAIR | 2.00 | 0 | 0 | 0 | X | ||
| KEVIN R RYAN | |||||||
| SECRETARY/TR | 2.00 | 0 | 0 | 0 | X | ||
| LOUIS DEGENNARO | |||||||
| EVP,CHIEF MI | 45.00 | 346056 | 0 | 39109 | X | ||
| NANCY KLEIN | |||||||
| CHIEF MARKET | 45.00 | 337570 | 0 | 46123 | X | ||
| DAVID TIMKO | |||||||
| SVP CHAPTER | 45.00 | 247464 | 0 | 38060 | X | ||
| MICHAEL OSSO | |||||||
| SVP,REVENUE | 45.00 | 230521 | 0 | 29514 | X | ||
| GEORGE OMIROS | |||||||
| SVP FIELD DE | 45.00 | 219956 | 0 | 35609 | X | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | 2133908 | TotalReportableCompFromOrg |
| Total Other Compensation | 284815 | TotalOtherCompensation |
| Number Individuals GT100 K | 86 | NumberIndividualsGT100K |
| Formers Listed | false | FormersListed |
| Total Comp GT150 K | true | TotalCompGT150K |
| Compensation From Other Sources | false | CompensationFromOtherSources |
Contractor Compensation ContractorCompensation (5 entries)
| Address Line1AddressOfContractor/AddressUS/AddressLine1 | Address Line2AddressOfContractor/AddressUS/AddressLine2 | CityAddressOfContractor/AddressUS/City | StateAddressOfContractor/AddressUS/State | ZIP CodeAddressOfContractor/AddressUS/ZIPCode | Description Of ServicesDescriptionOfServices | CompensationCompensation |
|---|---|---|---|---|---|---|
| PARADYZ MATERA | ||||||
| 5 HANOVER SQUARE | 6TH FLOOR | NEW YORK | NY | 10004 | FUNDRAISING SER | 3852425 |
| DIRECT PRINT COMMUNICATIONS | ||||||
| 201 EAST SANDPOINTE | SUITE 400 | SANTA ANA | CA | 92707 | FUNDRAISING SER | 2515663 |
| INFOCISION MANAGEMENT CORPORATION | ||||||
| 325 SPRINGSIDE DRIVE | AKRON | OH | 44333 | FUNDRAISING SER | 2210192 | |
| MSP | ||||||
| PO BOX 641114 | PITTSBURGH | PA | 15264 | FUNDRAISING SER | 2100315 | |
| YORK LABEL | ||||||
| 36877 TREASURY CENTER | CHICAGO | IL | 60694 | FUNDRAISING SER | 1653978 | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Number Of Contractors GT100 K | 55 | NumberOfContractorsGT100K |
| Federated Campaigns | 2465953 | FederatedCampaigns |
| Fundraising Events | 154840995 | FundraisingEvents |
| Government Grants | 520836 | GovernmentGrants |
| All Other Contributions | 112537137 | AllOtherContributions |
| Noncash Contributions | 962451 | NoncashContributions |
| Total Contributions | 270364921 | TotalContributions |
Investment Income InvestmentIncome
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 3135664 | TotalRevenueColumn |
| Exclusion | $3,135,664 | ExclusionAmount |
Royalties Revenue RoyaltiesRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 9973 | TotalRevenueColumn |
| Exclusion | $9,973 | ExclusionAmount |
Gross Amount Sales Assets GrossAmountSalesAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 59867900 | Securities |
Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 52012920 | Securities |
Gain Or Loss GainOrLoss
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 7854980 | Securities |
Net Gain Or Loss Investments NetGainOrLossInvestments
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 7854980 | TotalRevenueColumn |
| Unrelated Business Revenue | -1562 | UnrelatedBusinessRevenue |
| Exclusion | $7,856,542 | ExclusionAmount |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Income Fundraising Events | 36412083 | GrossIncomeFundraisingEvents |
| Cntrbtns Rprtd Fundraising Events | 154840995 | CntrbtnsRprtdFundraisingEvents |
| Fundraising Direct Expenses | 36412083 | FundraisingDirectExpenses |
| Gross Income Gaming | 738168 | GrossIncomeGaming |
| Gaming Direct Expenses | 50690 | GamingDirectExpenses |
Net Income From Gaming NetIncomeFromGaming
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 687478 | TotalRevenueColumn |
| Related Or Exempt Function Income | 687478 | RelatedOrExemptFunctionIncome |
Other Revenue Misc OtherRevenueMisc (2 entries)
| DescriptionDescription | Business CodeBusinessCode | Total Revenue ColumnTotalRevenueColumn | ExclusionExclusionAmount |
|---|---|---|---|
| GRANT TERMINATION | 541900 | 1748113 | $1,748,113 |
| OTHER MISCELLANEOUS | 900099 | 31372 | $31,372 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Revenue | 1779485 | TotalOtherRevenue |
Total Revenue TotalRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 283832501 | TotalRevenueColumn |
| Related Or Exempt Function Income | 687478 | RelatedOrExemptFunctionIncome |
| Unrelated Business Revenue | -1562 | UnrelatedBusinessRevenue |
| Exclusion | $12,781,664 | ExclusionAmount |
Grants To Domestic Orgs GrantsToDomesticOrgs
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 61294057 | Total |
| Program Services | 61294057 | ProgramServices |
Grants To Domestic Individuals GrantsToDomesticIndividuals
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 43526311 | Total |
| Program Services | 43526311 | ProgramServices |
Foreign Grants ForeignGrants
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 4788127 | Total |
| Program Services | 4788127 | ProgramServices |
Comp Current Officers Directors CompCurrentOfficersDirectors
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 895935 | Total |
| Program Services | 675482 | ProgramServices |
| Management And General | 99303 | ManagementAndGeneral |
| Fundraising | 121150 | Fundraising |
Other Salaries And Wages OtherSalariesAndWages
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 63212997 | Total |
| Program Services | 47658872 | ProgramServices |
| Management And General | 7006360 | ManagementAndGeneral |
| Fundraising | 8547765 | Fundraising |
Pension Plan Contributions PensionPlanContributions
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 3916306 | Total |
| Program Services | 2852862 | ProgramServices |
| Management And General | 421859 | ManagementAndGeneral |
| Fundraising | 641585 | Fundraising |
Other Employee Benefits OtherEmployeeBenefits
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 10999355 | Total |
| Program Services | 8012560 | ProgramServices |
| Management And General | 1184836 | ManagementAndGeneral |
| Fundraising | 1801959 | Fundraising |
Payroll Taxes PayrollTaxes
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 4634264 | Total |
| Program Services | 3375863 | ProgramServices |
| Management And General | 499197 | ManagementAndGeneral |
| Fundraising | 759204 | Fundraising |
Fees For Services Legal FeesForServicesLegal
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 890419 | Total |
| Program Services | 500182 | ProgramServices |
| Management And General | 133314 | ManagementAndGeneral |
| Fundraising | 256923 | Fundraising |
Fees For Services Accounting FeesForServicesAccounting
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 284308 | Total |
| Program Services | 159706 | ProgramServices |
| Management And General | 42567 | ManagementAndGeneral |
| Fundraising | 82035 | Fundraising |
Fees For Services Lobbying FeesForServicesLobbying
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 164800 | Total |
| Program Services | 92572 | ProgramServices |
| Management And General | 24674 | ManagementAndGeneral |
| Fundraising | 47554 | Fundraising |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 9810826 | Total |
| Fundraising | 9810826 | Fundraising |
Fees For Services Invst Mgmnt Fees FeesForServicesInvstMgmntFees
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 701540 | Total |
| Program Services | 394081 | ProgramServices |
| Management And General | 105036 | ManagementAndGeneral |
| Fundraising | 202423 | Fundraising |
Fees For Services Other FeesForServicesOther
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 14394331 | Total |
| Program Services | 8085841 | ProgramServices |
| Management And General | 2155133 | ManagementAndGeneral |
| Fundraising | 4153357 | Fundraising |
Advertising Advertising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 4106918 | Total |
| Program Services | 1762928 | ProgramServices |
| Management And General | 759276 | ManagementAndGeneral |
| Fundraising | 1584714 | Fundraising |
Information Technology InformationTechnology
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 3845633 | Total |
| Program Services | 2160237 | ProgramServices |
| Management And General | 575772 | ManagementAndGeneral |
| Fundraising | 1109624 | Fundraising |
Occupancy Occupancy
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 8212389 | Total |
| Program Services | 5984218 | ProgramServices |
| Management And General | 944956 | ManagementAndGeneral |
| Fundraising | 1283215 | Fundraising |
Travel Travel
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 3320436 | Total |
| Program Services | 2445830 | ProgramServices |
| Management And General | 394227 | ManagementAndGeneral |
| Fundraising | 480379 | Fundraising |
Conferences Meetings ConferencesMeetings
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 3251767 | Total |
| Program Services | 2848153 | ProgramServices |
| Management And General | 180213 | ManagementAndGeneral |
| Fundraising | 223401 | Fundraising |
Depreciation Depletion DepreciationDepletion
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 2054800 | Total |
| Program Services | 1448640 | ProgramServices |
| Management And General | 205648 | ManagementAndGeneral |
| Fundraising | 400512 | Fundraising |
Insurance Insurance
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 515497 | Total |
| Program Services | 377947 | ProgramServices |
| Management And General | 45472 | ManagementAndGeneral |
| Fundraising | 92078 | Fundraising |
Other Expenses OtherExpenses (5 entries)
| DescriptionDescription | TotalTotal | Program ServicesProgramServices | Management And GeneralManagementAndGeneral | FundraisingFundraising |
|---|---|---|---|---|
| PRINTING | 17782487 | 7633273 | 3287580 | 6861634 |
| POSTAGE | 11658784 | 4325172 | 1844493 | 5489119 |
| TELEPHONE | 3560220 | 2304559 | 268953 | 986708 |
| MISCELLANEOUS | 2747539 | 2034503 | 307388 | 405648 |
| DUES & SUBSCRIPTIONS | 271078 | 116362 | 50116 | 104600 |
Total Functional Expenses TotalFunctionalExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 280841124 | Total |
| Program Services | 214858338 | ProgramServices |
| Management And General | 20536373 | ManagementAndGeneral |
| Fundraising | 45446413 | Fundraising |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Joint Costs | X | JointCosts |
Total Joint Costs TotalJointCosts
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 21788322 | Total |
| Program Services | 10485257 | ProgramServices |
| Fundraising | 11303065 | Fundraising |
Savings And Temp Cash Investments SavingsAndTempCashInvestments
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 19677285 | BOY |
| EOY | 15624105 | EOY |
Pledges And Grants Receivable PledgesAndGrantsReceivable
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 16815436 | BOY |
| EOY | 19055089 | EOY |
Accounts Receivable AccountsReceivable
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 199138 | BOY |
| EOY | 328134 | EOY |
Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 4262608 | BOY |
| EOY | 4423864 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Buildings Equipment Basis | 13640725 | LandBuildingsEquipmentBasis |
| Land Bldg Equipment Accum Deprec | 8458416 | LandBldgEquipmentAccumDeprec |
Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 5006438 | BOY |
| EOY | 5182309 | EOY |
Investments Pub Traded Securities InvestmentsPubTradedSecurities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 128755483 | BOY |
| EOY | 128104890 | EOY |
Investments Other Securities InvestmentsOtherSecurities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 46943952 | BOY |
| EOY | 51553483 | EOY |
Total Assets TotalAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 221660340 | BOY |
| EOY | 224271874 | EOY |
Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 15911173 | BOY |
| EOY | 17155530 | EOY |
Grants Payable GrantsPayable
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 79972494 | BOY |
| EOY | 70833146 | EOY |
Deferred Revenue DeferredRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 16329604 | BOY |
| EOY | 16499305 | EOY |
Total Liabilities TotalLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 112213271 | BOY |
| EOY | 104487981 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Follow SFAS117 | X | FollowSFAS117 |
Unrestricted Net Assets UnrestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 87166990 | BOY |
| EOY | 93670008 | EOY |
Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 19507519 | BOY |
| EOY | 23328394 | EOY |
Permanently Restricted Net Assets PermanentlyRestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 2772560 | BOY |
| EOY | 2785491 | EOY |
Total Net Assets Fund Balances TotalNetAssetsFundBalances
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 109447069 | BOY |
| EOY | 119783893 | EOY |
Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 221660340 | BOY |
| EOY | 224271874 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | X | InfoInScheduleOPartXI |
| Reconcilation Revenue Expenses | 2991377 | ReconcilationRevenueExpenses |
| Reconcilation Other Changes | 7345447 | ReconcilationOtherChanges |
| Method Of Accounting Accrual | X | MethodOfAccountingAccrual |
| Accountant Compile Or Review | false | AccountantCompileOrReview |
| FS Audited | true | FSAudited |
| Audit Committee | true | AuditCommittee |
| Financial Statement Separate | X | FinancialStatementSeparate |
| Federal Grant Audit Required | false | FederalGrantAuditRequired |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Publicly Supported Org170b1 Avi | X | PubliclySupportedOrg170b1Avi |
Gifts Grants Contrib Received170 GiftsGrantsContribReceived170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 246772831 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 256914242 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 269310797 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 238864532 | CurrentTaxYearMinus1Year |
| Current Tax Year | 271052399 | CurrentTaxYear |
| Total | 1282914801 | Total |
Total170 Total170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 246772831 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 256914242 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 269310797 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 238864532 | CurrentTaxYearMinus1Year |
| Current Tax Year | 271052399 | CurrentTaxYear |
| Total | 1282914801 | Total |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Amounts Subst Contributors Total | 32756803 | AmountsSubstContributorsTotal |
| Public Support Total170 | 1250157998 | PublicSupportTotal170 |
Gross Investment Income170 GrossInvestmentIncome170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 6538216 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 7451748 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 6950554 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 4962639 | CurrentTaxYearMinus1Year |
| Current Tax Year | 3145637 | CurrentTaxYear |
| Total | 29048794 | Total |
Other Income170 OtherIncome170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 1446752 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 1098580 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 2816918 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 1925834 | CurrentTaxYearMinus1Year |
| Current Tax Year | 1779485 | CurrentTaxYear |
| Total | 9067569 | Total |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | 1321031164 | TotalSupport |
| Gross Receipts From Admissions Etc | 192137673 | GrossReceiptsFromAdmissionsEtc |
| Public Support Pertcentage170 | 0.94640 | PublicSupportPertcentage170 |
| Public Support Pertcent Prior Year | 0.96910 | PublicSupportPertcentPriorYear |
| Thirty Three Percnt Tests CY170 | X | ThirtyThreePercntTestsCY170 |
Schedule B IRS990ScheduleB
Contributor Info ContributorInfo
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor Number | RESTRICTED | ContributorNumber |
Contributor Name Business ContributorNameBusiness
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor Address US ContributorAddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Aggregate Contributions | RESTRICTED | AggregateContributions |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form4720 Filed4955 Tax | false | Form4720Filed4955Tax |
| Correction Made | false | CorrectionMade |
| Form1120 Pol Filed | false | Form1120PolFiled |
| Form4720 Filed | false | Form4720Filed |
| Volunteers | true | Volunteers |
| Paid Staff Or Management | true | PaidStaffOrManagement |
| Media Advertisements | false | MediaAdvertisements |
| Mailings Members | true | MailingsMembers |
| Mailings Members | $30,000 | MailingsMembersAmount |
| Publications Or Broadcast | true | PublicationsOrBroadcast |
| Publications Or Broadcast | $8,000 | PublicationsOrBroadcastAmount |
| Grants Other Organizations | false | GrantsOtherOrganizations |
| Direct Contact Legislators | true | DirectContactLegislators |
| Rallies Demonstrations | true | RalliesDemonstrations |
| Rallies Demonstrations | $110,000 | RalliesDemonstrationsAmount |
| Other Activities | true | OtherActivities |
| Other Activities | $16,800 | OtherActivitiesAmount |
| Total Lobbying Expenditures IIB | 164800 | TotalLobbyingExpendituresIIB |
| Not Described In501c3 | false | NotDescribedIn501c3 |
| Form4720 Filed4912 Tax | false | Form4720Filed4912Tax |
| Substantially All Dues Nondeduct | false | SubstantiallyAllDuesNondeduct |
| Only In House Lobbying | false | OnlyInHouseLobbying |
| Agree To Carryover Prior Year | false | AgreeToCarryoverPriorYear |
Form990 Schedule C Part IV Form990ScheduleCPartIV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Reference | SCHEDULE C, PART II-B, LINE 1I | ReturnReference |
| Explanation | LLS IS A MEMBER OF A NUMBER OF COALITIONS INCLUDING RESEARCH AMERICA, ONE VOICE AGAINST CANCER, NATIONAL COALITION FOR CANCER RESEARCH,COALITION FOR THE ADVANCEMENT OF MEDICAL RESEARCH, AND ALLIANCE FOR A STRONGER FDA. | Explanation |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Disclosed Orgs Legal Control | false | DisclosedOrgsLegalControl |
| Disclosed For Charitable Purposes | false | DisclosedForCharitablePurposes |
| Written Policy Monitoring | false | WrittenPolicyMonitoring |
| Sect170h Requirements Satisfied | false | Sect170hRequirementsSatisfied |
| Collect Used For Public Exhibition | X | CollectUsedForPublicExhibition |
| Solicited Assets For Sale | false | SolicitedAssetsForSale |
| Agent Trustee Etc | false | AgentTrusteeEtc |
| Included On FS | false | IncludedOnFS |
Current Year CurrentYear
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Of Year Balance | 5023902 | BeginningOfYearBalance |
| Contributions | 111064 | Contributions |
| Investment Earnings Or Losses | 938068 | InvestmentEarningsOrLosses |
| Administrative Expenses | -13040 | AdministrativeExpenses |
| End Of Year Balance | 6059994 | EndOfYearBalance |
Current Year Minus1 Year CurrentYearMinus1Year
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Of Year Balance | 4481610 | BeginningOfYearBalance |
| Investment Earnings Or Losses | 563236 | InvestmentEarningsOrLosses |
| Administrative Expenses | -20944 | AdministrativeExpenses |
| End Of Year Balance | 5023902 | EndOfYearBalance |
Current Year Minus2 Years CurrentYearMinus2Years
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Of Year Balance | 5228375 | BeginningOfYearBalance |
| Investment Earnings Or Losses | -730333 | InvestmentEarningsOrLosses |
| Administrative Expenses | -16432 | AdministrativeExpenses |
| End Of Year Balance | 4481610 | EndOfYearBalance |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Permanent Endowment EOY Balance | 0.54000 | PermanentEndowmentEOYBalance |
| Term Endowment EOY Balance | 0.46000 | TermEndowmentEOYBalance |
| Endowments Held By Unrelated Orgs | false | EndowmentsHeldByUnrelatedOrgs |
| Endowments Held By Related Orgs | false | EndowmentsHeldByRelatedOrgs |
| Are Related Orgs Listed Schedule R | false | AreRelatedOrgsListedScheduleR |
Leasehold Improvements LeaseholdImprovements
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 838350 | OtherCostOrOtherBasis |
| Depreciation | 657891 | Depreciation |
| Book Value | 180459 | BookValue |
Equipment Equipment
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 6909271 | OtherCostOrOtherBasis |
| Depreciation | 4369616 | Depreciation |
| Book Value | 2539655 | BookValue |
Other Land Buildings OtherLandBuildings
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 5893104 | OtherCostOrOtherBasis |
| Depreciation | 3430909 | Depreciation |
| Book Value | 2462195 | BookValue |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Book Value Land Buildings | 5182309 | TotalOfBookValueLandBuildings |
Other Securities OtherSecurities (5 entries)
| DescriptionDescription | Book ValueBookValue | Method Of ValuationMethodOfValuation |
|---|---|---|
| FUND OF HEDGE FUNDS-OPERATING | 34424715 | F |
| LIMITED PARTNERSHIP INDICIES-OPERATI | 14138404 | F |
| FUND OF HEDGE FUNDS-ENDOWMENT | 1020502 | F |
| LIMITED PARTNERSHIP INDICIES-ENDOWME | 996514 | F |
| PRINCIPAL 457B PLAN | 973348 | F |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Book Value Securities | 51553483 | TotalOfBookValueSecurities |
| Total Revenue | 283832501 | TotalRevenue |
| Total Expenses | 280841124 | TotalExpenses |
| Excess Or Deficit For Year | 2991377 | ExcessOrDeficitForYear |
| Net Unrealized GL On Investments | 7272440 | NetUnrealizedGLOnInvestments |
| Other | $168,183 | OtherAmount |
| Total Adjustments | 7440623 | TotalAdjustments |
| Excess Or Deficit Per FS | 10432000 | ExcessOrDeficitPerFS |
| Tot Revenue Etc Audited Fincl Stmt | 309187000 | TotRevenueEtcAuditedFinclStmt |
| Net Unrealized Gains Investments | 7272440 | NetUnrealizedGainsInvestments |
| Donated Srvc And Use Of Facilities | 5982875 | DonatedSrvcAndUseOfFacilities |
| Other Revenues | 12800724 | OtherRevenues |
| Revenue Not Rptd F990 | 26056039 | RevenueNotRptdF990 |
| Revenue Subtotal | 283130961 | RevenueSubtotal |
| Investment Expenses Not Included | 701540 | InvestmentExpensesNotIncluded |
| Revenue Not Rptd On Fin Stmt | 701540 | RevenueNotRptdOnFinStmt |
| Total Revenue Per Form990 | 283832501 | TotalRevenuePerForm990 |
| Tot Expenses Etc Audited Fincl Stmt | 299075000 | TotExpensesEtcAuditedFinclStmt |
| Donated Services Use Of Facilities | 5982875 | DonatedServicesUseOfFacilities |
| Other Expenses Included | 12952541 | OtherExpensesIncluded |
| Expenses Not Rptd F990 | 18935416 | ExpensesNotRptdF990 |
| Expenses Subtotal | 280139584 | ExpensesSubtotal |
| Investment Expenses Not Included2 | 701540 | InvestmentExpensesNotIncluded2 |
| Expenses Not Rptd On Fin Stmt | 701540 | ExpensesNotRptdOnFinStmt |
| Total Expenses Per Form990 | 280841124 | TotalExpensesPerForm990 |
Form990 Schedule D Part XIV Form990ScheduleDPartXIV (7 entries)
| IdentifierIdentifier | Return ReferenceReturnReference | ExplanationExplanation |
|---|---|---|
| COLLECTIONS AND RELATION TO EXEMPT PURPOSE | SCHEDULE D, PAGE 2, PART III, LINE 4 | THE LLS'S COLLECTION IS OF PHOTOGRAPHS WHICH ARE USED FOR PUBLIC EXHIBITION AT FUNDRAISING EVENTS HELD TO SUPPORT LLS'S PROGRAMS. |
| INTENDED USES FOR ENDOWMENT FUNDS | SCHEDULE D, PAGE 2, PART V, LINE 4 | LLS'S ENDOWMENTS ARE INTENDED TO FUND RESEARCH AS WELL AS SUPPORT LLS'S PUBLIC EDUCATION PROGRAMS. |
| LIABILITY UNDER FIN 48 FOOTNOTE | SCHEDULE D, PAGE 3, PART X | LLS RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY OF THOSE TAX POSITIONS THAT ARE MORE LIKELY THAN NOT TO BE SUSTAINED. INCOME GENERATED FROM ACTIVITIES UNRELATED TO LLS'S EXEMPT PURPOSE IS SUBJECT TO TAX UNDER INTERNAL REVENUE CODE SECTION 511. LLS DID NOT RECOGNIZE ANY UNRELATED INCOME TAX LIABILITY FOR THE YEARS ENDED JUNE 30, 2011 AND 2010. |
| RECONCILIATION OF CHANGES - OTHER | SCHEDULE D, PAGE 4, PART XI, LINE 8 | LSRP OTHER REVENUE 35,116 LLS CANADA REVENUE 12,766,323 ROUNDING FOR AUDITED STATEMENTS -715 LSRP EXPENSES -1,511 LLS CANADA EXPENSES -12,949,776 ROUNDING FOR AUDITED STATEMENTS -1,254 |
| REVENUE AMOUNTS INCLUDED IN FINANCIALS - OTHER | SCHEDULE D, PAGE 4, PART XII, LINE 2D | LSRP OTHER REVENUE 35,116 LLS CANADA REVENUE 12,766,323 ROUNDING FOR AUDITED STATEMENTS -715 |
| EXPENSE AMOUNTS INCLUDED IN FINANCIALS - OTHER | SCHEDULE D, PAGE 4, PART XIII, LINE 2D | LSRP EXPENSES 1,511 LLS CANADA EXPENSES 12,949,776 ROUNDING FOR AUDITED STATEMENTS 1,254 |
| SUPPLEMENTAL FINANCIAL INFORMATION | SCHEDULE D, PAGE 4, PART XIV | PART III, LINE 1A: THE LEUKEMIA & LYMPHOMA SOCIETY MAINTAINS A SMALL PHOTOGRAPH COLLECTION FOR PUBLIC EXHIBITION WHICH HAS AN ESTIMATED VALUE BETWEEN 20,000 AND 50,000. AS THIS REPRESENTS A RELATIVELY SMALL PERCENTAGE OF LLS'S ASSETS, IT IS NOT SEPARATELY DISCLOSED IN THE FINANCIAL STATEMENTS OR FOOTNOTES. |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | true | GrantRecordsMaintained |
Accts Actvs Out US Table AcctsActvsOutUSTable (5 entries)
| RegionRegion | Number Of OfficesNumberOfOffices | Number Of EmployeesNumberOfEmployees | Type Of Activities ConductedTypeOfActivitiesConducted | Specific Services ProvidedSpecificServicesProvided | Total ExpendituresTotalExpenditures |
|---|---|---|---|---|---|
| EAST ASIA | 2 | 2 | RESEARCH FUNDING | RESEARCH GRANTS | 300000 |
| MIDDLE EAST | 1 | 1 | RESEARCH FUNDING | RESEARCH GRANTS | 200000 |
| EUROPE | 8 | 8 | RESEARCH FUNDING | RESEARCH GRANTS | 1949500 |
| NORTH AMERICA | 18 | 18 | RESEARCH FUNDING | RESEARCH GRANTS | 2338626 |
| CENTRAL AMERICA & THE CARIBBEAN | 1 | 1 | INVESTMENTS | INVESTMENTS | 16736363 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Number Of Offices | 30 | SubtotalNumberOfOffices |
| Subtotal Number Of Employees | 30 | SubtotalNumberOfEmployees |
| Total Number Of Offices | 30 | TotalNumberOfOffices |
| Total Number Of Employees | 30 | TotalNumberOfEmployees |
| Subtotal Amount Spent | 21524489 | SubtotalAmountSpent |
| Total Amount Spent | 21524489 | TotalAmountSpent |
Grants To Orgs Outside US GrantsToOrgsOutsideUS (56 entries)
| RegionRegion | Purpose Of GrantPurposeOfGrant | Amount Of Cash GrantAmountOfCashGrant | Manner Of Cash DisbursementMannerOfCashDisbursement | Method Of ValuationMethodOfValuation |
|---|---|---|---|---|
| EAST ASIA & PACIFIC | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 55000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 55000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 55000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 55000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 110000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 65000 | CHECK | ACCRUAL |
| MIDDLE EAST & NORTH AFRICA | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| EUROPE | RESEARCH GRANT | 110000 | CHECK | ACCRUAL |
| EUROPE | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| EUROPE | RESEARCH GRANT | 65000 | CHECK | ACCRUAL |
| EAST ASIA & PACIFIC | RESEARCH GRANT | 100000 | CHECK | ACCRUAL |
| EUROPE | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| EUROPE | RESEARCH GRANT | 1250000 | CHECK | ACCRUAL |
| EUROPE | RESEARCH GRANT | 55000 | CHECK | ACCRUAL |
| EUROPE | RESEARCH GRANT | 55000 | CHECK | ACCRUAL |
| NORTH AMERICA | THERAPY ACCELERATION | 307026 | CHECK | FMV |
| NORTH AMERICA | THERAPY ACCELERATION | 112977 | CHECK | FMV |
| NORTH AMERICA | THERAPY ACCELERATION | 75000 | CHECK | FMV |
| NORTH AMERICA | THERAPY ACCELERATION | 48436 | CHECK | FMV |
| EUROPE | THERAPY ACCELERATION | 14500 | CHECK | FMV |
| EAST ASIA & PACIFIC | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 55000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 55000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 55000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 55000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 110000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| NORTH AMERICA | RESEARCH GRANT | 65000 | CHECK | ACCRUAL |
| MIDDLE EAST & NORTH AFRICA | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| EUROPE | RESEARCH GRANT | 110000 | CHECK | ACCRUAL |
| EUROPE | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| EUROPE | RESEARCH GRANT | 65000 | CHECK | ACCRUAL |
| EAST ASIA & PACIFIC | RESEARCH GRANT | 100000 | CHECK | ACCRUAL |
| EUROPE | RESEARCH GRANT | 200000 | CHECK | ACCRUAL |
| EUROPE | RESEARCH GRANT | 1250000 | CHECK | ACCRUAL |
| EUROPE | RESEARCH GRANT | 55000 | CHECK | ACCRUAL |
| EUROPE | RESEARCH GRANT | 55000 | CHECK | ACCRUAL |
| NORTH AMERICA | THERAPY ACCELERATION | 307026 | CHECK | FMV |
| NORTH AMERICA | THERAPY ACCELERATION | 112977 | CHECK | FMV |
| NORTH AMERICA | THERAPY ACCELERATION | 75000 | CHECK | FMV |
| NORTH AMERICA | THERAPY ACCELERATION | 48436 | CHECK | FMV |
| EUROPE | THERAPY ACCELERATION | 14500 | CHECK | FMV |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Number Of Other Orgs | 29 | TotalNumberOfOtherOrgs |
Form990 Schedule F Part V Form990ScheduleFPartV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | PROCEDURES FOR MONITORING THE USE OF GRANT FUNDS OUTSIDE THE UNITED STATES | Identifier |
| Return Reference | SCHEDULE F, PAGE 1, PART I, LINE 2 | ReturnReference |
| Explanation | FIDUCIARY RESPONSIBILITY AND TRANSPARENCY TO OUR DONORS IS A HIGH PRIORITY. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) PLACES CONSIDERABLE EMPHASIS ON THE OVERSIGHT OF GRANT SPENDING. TO ACCOMPLISH THIS WE REQUIRE THE SUBMISSION OF ANNUAL FINANCIAL REPORTS FOR EACH OF OUR ACTIVE GRANTS. THE REPORT MUST BE SIGNED BY THE FINANCIAL OFFICER AND/OR THE DESIGNATED OFFICIAL OF THE INSTITUTION HOSTING THE AWARD. AT THE END OF THE GRANT, WE REQUIRE A FINAL FINANCIAL REPORT THAT PROVIDES AN OVERVIEW OF ALL SPENDING THROUGH THE DURATION OF THE AWARD. WE REQUIRE SPECIFIC ACCOUNTING OF SPENDING ON PERSONNEL, CONSULTANTS,EQUIPMENT PURCHASES, SUPPLIES, TRAVEL, PATIENT CARE COSTS, ANIMAL CARE COSTS, AND ANY OTHER EXPENSE A GRANTEE MAY INCUR. WE HAVE SPECIFIC INSTRUCTIONS AND DOLLAR AMOUNT LIMITATIONS SET FOR MANY OF THESE CATEGORIES DEPENDING ON THE AWARD TYPE. FINANCIAL REPORTS ARE REVIEWED FOR NUMERICAL ACCURACY, ADHERENCE TO OUR GUIDELINES, AND FOR THE VERIFICATION OF APPROVAL FROM THE INSTITUTION'S FINANCIAL OFFICER. IF THE GRANTEE DOES NOT SUBMIT AN ANNUAL FINANCIAL REPORT BY THE DUE DATE OUTLINED IN THEIR CONTRACT, FUNDING IS SUSPENDED UNTIL LLS RECEIVES AND APPROVES THE DELINQUENT REPORT. | Explanation |
Schedule G IRS990ScheduleG
| Field | Value | IRS element (for citing) |
|---|---|---|
| Mail Solicitations | X | MailSolicitations |
| Email Solicitations | X | EmailSolicitations |
| Phone Solicitations | X | PhoneSolicitations |
| In Person Solicitations | X | InPersonSolicitations |
| Solicitation Of Non Govt Grants | X | SolicitationOfNonGovtGrants |
| Solicitation Of Govt Grants | X | SolicitationOfGovtGrants |
| Special Fundraising Events | X | SpecialFundraisingEvents |
| Agreement Ref Fundraising | true | AgreementRefFundraising |
Fundraiser Activity Information FundraiserActivityInformation (6 entries)
| Name Of IndividualNameOfIndividual | Address Line1AddressUS/AddressLine1 | Address Line2AddressUS/AddressLine2 | CityAddressUS/City | StateAddressUS/State | ZIP CodeAddressUS/ZIPCode | ActivityActivity | Fundraiser Control Of FundsFundraiserControlOfFunds | Amount Retained By ContractorAmountRetainedByContractor | Net To OrganizationNetToOrganization |
|---|---|---|---|---|---|---|---|---|---|
| PARADYZ DIRECT | 5 HANOVER SQUARE | SIXTH FLOOR | NEW YORK | NY | 10004 | DIRECT MAI | false | 3852425 | -3852425 |
| DIRECT PRINT COMMUNICATIONS | 201 EAST SANDPOINTE | SUITE 400 | SANTA ANA | CA | 92707 | DIRECT MAI | false | 2515663 | -2515663 |
| INFOCISION | 325 SPRINGSIDE DRIVE | AKRON | OH | 44333 | TELEMARKET | false | 2210192 | -2210192 | |
| THOMPSON HABIB DENISON | 80 HAYDEN AVENUE | SUITE 300 | LEXINGTON | MA | 02421 | DIRECT MAI | false | 605325 | -605325 |
| HANINES COMPANY | 8050 FREEDOM AVENUE | CANTON | OH | 44720 | TELEMARKET | false | 417716 | -417716 | |
| PIDIBLACKBAUD | 1800 DIAGONAL RAOD | SUITE 400 | ALEXANDRIA | VA | 22314 | DIRECT MAI | false | 209505 | -209505 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Retained By Contractors | 9810826 | TotalRetainedByContractors |
| All States | All States | AllStates |
Events Information EventsInformation
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Of Event1 | NIKE WOMENS MAR | NameOfEvent1 |
| Gross Receipts Event1 | 11111394 | GrossReceiptsEvent1 |
| Charitable Contributions Event1 | 8308343 | CharitableContributionsEvent1 |
| Gross Revenue Event1 | 2803051 | GrossRevenueEvent1 |
| Other Direct Expenses Event1 | 2803051 | OtherDirectExpensesEvent1 |
| Name Of Event2 | ROCK N ROLL MAR | NameOfEvent2 |
| Gross Receipts Event2 | 8301245 | GrossReceiptsEvent2 |
| Charitable Contributions Event2 | 5723636 | CharitableContributionsEvent2 |
| Gross Revenue Event2 | 2577609 | GrossRevenueEvent2 |
| Other Direct Expenses Event2 | 2577609 | OtherDirectExpensesEvent2 |
| Total Number Of Other Events | 720 | TotalNumberOfOtherEvents |
| Gross Receipts Other Events | 171840439 | GrossReceiptsOtherEvents |
| Charitable Contrib Other Events | 140809016 | CharitableContribOtherEvents |
| Gross Revenue Other Events | 31031423 | GrossRevenueOtherEvents |
| Other Direct Expenses Other Events | 31031423 | OtherDirectExpensesOtherEvents |
| Gross Receipts Total | 191253078 | GrossReceiptsTotal |
| Charitable Contributions Total | 154840995 | CharitableContributionsTotal |
| Gross Revenue Total Events | 36412083 | GrossRevenueTotalEvents |
| Other Direct Expenses Total Events | 36412083 | OtherDirectExpensesTotalEvents |
| Direct Expense Summary Events | 36412083 | DirectExpenseSummaryEvents |
Gaming Information GamingInformation
| Field | Value | IRS element (for citing) |
|---|---|---|
| Volunteer Labor Bingo | false | VolunteerLaborBingo |
| Volunteer Labor Pull Tabs | false | VolunteerLaborPullTabs |
| Gross Revenue Other Gaming | 738168 | GrossRevenueOtherGaming |
| Cash Prizes Other Gaming | 8615 | CashPrizesOtherGaming |
| Non Cash Prizes Other Gaming | 38437 | NonCashPrizesOtherGaming |
| Other Direct Expenses Other Gaming | 3638 | OtherDirectExpensesOtherGaming |
| Volunteer Labor Other Gaming | true | VolunteerLaborOtherGaming |
| Volunteer Labor Prcnt Other Gaming | 0.06000 | VolunteerLaborPrcntOtherGaming |
| Gross Revenue Total Gaming | 738168 | GrossRevenueTotalGaming |
| Cash Prizes Total Gaming | 8615 | CashPrizesTotalGaming |
| Non Cash Prizes Total Gaming | 38437 | NonCashPrizesTotalGaming |
| Other Direct Expenses Total Gaming | 3638 | OtherDirectExpensesTotalGaming |
| Direct Expense Summary Gaming | 50690 | DirectExpenseSummaryGaming |
| Net Gaming Income Summary | 687478 | NetGamingIncomeSummary |
| Field | Value | IRS element (for citing) |
|---|---|---|
| States Where Gaming Conducted | AK | StatesWhereGamingConducted |
| States Where Gaming Conducted | AZ | StatesWhereGamingConducted |
| States Where Gaming Conducted | CA | StatesWhereGamingConducted |
| States Where Gaming Conducted | CT | StatesWhereGamingConducted |
| States Where Gaming Conducted | DC | StatesWhereGamingConducted |
| States Where Gaming Conducted | FL | StatesWhereGamingConducted |
| States Where Gaming Conducted | GA | StatesWhereGamingConducted |
| States Where Gaming Conducted | LA | StatesWhereGamingConducted |
| States Where Gaming Conducted | MA | StatesWhereGamingConducted |
| States Where Gaming Conducted | MD | StatesWhereGamingConducted |
| States Where Gaming Conducted | MI | StatesWhereGamingConducted |
| States Where Gaming Conducted | MN | StatesWhereGamingConducted |
| States Where Gaming Conducted | MS | StatesWhereGamingConducted |
| States Where Gaming Conducted | NJ | StatesWhereGamingConducted |
| States Where Gaming Conducted | NV | StatesWhereGamingConducted |
| States Where Gaming Conducted | NY | StatesWhereGamingConducted |
| States Where Gaming Conducted | OH | StatesWhereGamingConducted |
| States Where Gaming Conducted | PA | StatesWhereGamingConducted |
| States Where Gaming Conducted | RI | StatesWhereGamingConducted |
| States Where Gaming Conducted | TX | StatesWhereGamingConducted |
| States Where Gaming Conducted | VA | StatesWhereGamingConducted |
| States Where Gaming Conducted | WA | StatesWhereGamingConducted |
| States Where Gaming Conducted | WI | StatesWhereGamingConducted |
| Licensed | true | Licensed |
| License Suspended Etc | false | LicenseSuspendedEtc |
| Gaming With Nonmembers | false | GamingWithNonmembers |
| Member Of Other Entity | false | MemberOfOtherEntity |
| Percentage Of Gaming Othr Facility | 1.00000 | PercentageOfGamingOthrFacility |
| Name Of Gaming Rec Keeper Person | JAMES T NANGLE | NameOfGamingRecKeeperPerson |
Address Of Gaming Rec Keeper US AddressOfGamingRecKeeperUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1311 MAMARONECK AVENUE | AddressLine1 |
| City | WHITE PLAINS | City |
| State | NY | State |
| ZIP Code | 10605 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contract With3rd Party For Gam Rev | false | ContractWith3rdPartyForGamRev |
| Charitable Distrib Required | false | CharitableDistribRequired |
Form990 Schedule G Part IV Form990ScheduleGPartIV (2 entries)
| IdentifierIdentifier | Return ReferenceReturnReference | ExplanationExplanation |
|---|---|---|
| STATES WITH GAMING OPERATIONS | SCHEDULE G PAGE 2 PART III LINE 9 | ALASKA ARIZONA CALIFORNIA CONNECTICUT DIST OF COLUMBIA FLORIDA GEORGIA LOUISIANA MASSACHUSETTS MARYLAND MICHIGAN MINNESOTA MISSISSIPPI NEW JERSEY NEVADA NEW YORK OHIO PENNSYLVANIA RHODE ISLAND TEXAS VIRGINIA WASHINGTON WISCONSIN |
| SCHEDULE G PART I LINE 2B LLS USED INFOCISION HAINES CO AND THOMPSON HABIB DENISON FOR ITS NATIONAL COMMUNITY CAMPAIGN AND DIRECT MAIL PROGRAMSTHESE PROGRAMS GENERATED GROSS RECEIPTS OF 31409474 DURING FISCAL YEAR 2011 LLS USED DIRECT PRINT COMMUNICATIONS PARADYSZ MATERA AND PIDIBLACKBAUD FOR ALL OF ITS OTHER FUNDRAISING EVENTS |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Records Maintained | true | RecordsMaintained |
Recipient Table RecipientTable (278 entries)
| Business Name Line2RecipientNameBusiness/BusinessNameLine2 | Address Line1AddressUS/AddressLine1 | Address Line2AddressUS/AddressLine2 | CityAddressUS/City | StateAddressUS/State | ZIP CodeAddressUS/ZIPCode | EIN Of RecipientEINOfRecipient | IRC SectionIRCSection | Amount Of Cash GrantAmountOfCashGrant | Method Of ValuationMethodOfValuation | Purpose Of GrantPurposeOfGrant |
|---|---|---|---|---|---|---|---|---|---|---|
| MAYO CLINIC ARIZONA DBA MAYO CLI | ||||||||||
| MAYO CLINIC ARIZONA D/B/A MAYO CLI | 13400 EAST SHEA BOULEVARD | 13400 EAST SHEA BOULEVARD | SCOTTSDALE | AZ | 85250 | 860800150 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| BECKMAN RESEARCH INSTITUTE OF THE C | ||||||||||
| BECKMAN RESEARCH INSTITUTE OF THE C | 1500 EAST DUARTE ROAD | 1500 EAST DUARTE ROAD | DUARTE | CA | 91010 | 953432210 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| BECKMAN RESEARCH INSTITUTE OF THE C | ||||||||||
| BECKMAN RESEARCH INSTITUTE OF THE C | 1500 EAST DUARTE ROAD | 1500 EAST DUARTE ROAD | DUARTE | CA | 91010 | 953432210 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| BECKMAN RESEARCH INSTITUTE OF THE C | ||||||||||
| BECKMAN RESEARCH INSTITUTE OF THE C | 1500 EAST DUARTE ROAD | 1500 EAST DUARTE ROAD | DUARTE | CA | 91010 | 953432210 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| LA JOLLA INSTITUTE FOR ALLERGY & IM | ||||||||||
| LA JOLLA INSTITUTE FOR ALLERGY & IM | 9420 ATHENA CIRCLE | 9420 ATHENA CIRCLE | LA JOLLA | CA | 92037 | 330328688 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| LA JOLLA INSTITUTE FOR ALLERGY & IM | ||||||||||
| LA JOLLA INSTITUTE FOR ALLERGY & IM | 9420 ATHENA CIRCLE | 9420 ATHENA CIRCLE | LA JOLLA | CA | 92037 | 330328688 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| LA JOLLA INSTITUTE FOR ALLERGY & IM | ||||||||||
| LA JOLLA INSTITUTE FOR ALLERGY & IM | 9420 ATHENA CIRCLE | 9420 ATHENA CIRCLE | LA JOLLA | CA | 92037 | 330328688 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| STANFORD UNIVERSITY | ||||||||||
| STANFORD UNIVERSITY | 9500 GILMAN DRIVE | 9500 GILMAN DRIVE | LA JOLLA | CA | 92037 | 237121131 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| THE SALK INSTITUTE FOR BIOLOGICAL S | ||||||||||
| THE SALK INSTITUTE FOR BIOLOGICAL S | 10010 NORTH TORREY PINES ROAD | 10010 NORTH TORREY PINES ROAD | LA JOLLA | CA | 92037 | 952160097 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| THE SCRIPPS RESEARCH INSTITUTE | ||||||||||
| THE SCRIPPS RESEARCH INSTITUTE | 10550 NORTH TORREY PINES ROAD | 10550 NORTH TORREY PINES ROAD | LA JOLLA | CA | 92037 | 330435954 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| THE SCRIPPS RESEARCH INSTITUTE | ||||||||||
| THE SCRIPPS RESEARCH INSTITUTE | 10550 NORTH TORREY PINES ROAD | 10550 NORTH TORREY PINES ROAD | LA JOLLA | CA | 92037 | 330435954 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| THE SCRIPPS RESEARCH INSTITUTE | ||||||||||
| THE SCRIPPS RESEARCH INSTITUTE | 10550 NORTH TORREY PINES ROAD | 10550 NORTH TORREY PINES ROAD | LA JOLLA | CA | 92037 | 330435954 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN DIEGO | ||||||||||
| UNIVERSITY OF CALIFORNIA SAN DIEGO | 9500 GILMAN DRIVE | 9500 GILMAN DRIVE | LA JOLLA | CA | 92037 | 956006144 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN DIEGO | ||||||||||
| UNIVERSITY OF CALIFORNIA SAN DIEGO | 9500 GILMAN DRIVE | 9500 GILMAN DRIVE | LA JOLLA | CA | 92037 | 956006144 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN DIEGO | ||||||||||
| UNIVERSITY OF CALIFORNIA SAN DIEGO | 9500 GILMAN DRIVE | 9500 GILMAN DRIVE | LA JOLLA | CA | 92037 | 956006144 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| CHILDRENS HOSPITAL LOS ANGELES | ||||||||||
| CHILDRENS HOSPITAL LOS ANGELES | 4650 SUNSET BLVD | 4650 SUNSET BLVD | LOS ANGELES | CA | 90001 | 951690977 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| CHILDRENS HOSPITAL LOS ANGELES | ||||||||||
| CHILDRENS HOSPITAL LOS ANGELES | 4650 SUNSET BLVD | 4650 SUNSET BLVD | LOS ANGELES | CA | 90001 | 951690977 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA LOS ANGEL | ||||||||||
| UNIVERSITY OF CALIFORNIA LOS ANGEL | 11000 KINROSS AVENUE | 11000 KINROSS AVENUE | LOS ANGELES | CA | 90001 | 956006143 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA LOS ANGEL | ||||||||||
| UNIVERSITY OF CALIFORNIA LOS ANGEL | 11000 KINROSS AVENUE | 11000 KINROSS AVENUE | LOS ANGELES | CA | 90001 | 956006143 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA LOS ANGEL | ||||||||||
| UNIVERSITY OF CALIFORNIA LOS ANGEL | 11000 KINROSS AVENUE | 11000 KINROSS AVENUE | LOS ANGELES | CA | 90001 | 956006143 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| NANOSYN INC | ||||||||||
| NANOSYN INC | 3760 MAVEN AVE | 3760 MAVEN AVE | MENLO PARK | CA | 94025 | 860909295 | 422500 | FMV | THERAPY ACCELERATION | |
| UNIVERSITY OF CALIFORNIA BERKELEY | ||||||||||
| UNIVERSITY OF CALIFORNIA BERKELEY | 1111 FRANKLIN ST | 1111 FRANKLIN ST | OAKLAND | CA | 94601 | 946002123 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA BERKELEY | ||||||||||
| UNIVERSITY OF CALIFORNIA BERKELEY | 1111 FRANKLIN ST | 1111 FRANKLIN ST | OAKLAND | CA | 94601 | 946002123 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| CALIFORNIA INSTITUTE OF TECHNOLOGY | ||||||||||
| CALIFORNIA INSTITUTE OF TECHNOLOGY | 263 S CHESTER AVENUE | 263 S CHESTER AVENUE | PASADENA | CA | 91101 | 951643307 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | ||||||||||
| UNIVERSITY OF CALIFORNIA SAN FRANC | 513 PARNASSUS AVENUE | 513 PARNASSUS AVENUE | SAN FRANCISCO | CA | 94102 | 946036493 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | ||||||||||
| UNIVERSITY OF CALIFORNIA SAN FRANC | 513 PARNASSUS AVENUE | 513 PARNASSUS AVENUE | SAN FRANCISCO | CA | 94102 | 946036493 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | ||||||||||
| UNIVERSITY OF CALIFORNIA SAN FRANC | 513 PARNASSUS AVENUE | 513 PARNASSUS AVENUE | SAN FRANCISCO | CA | 94102 | 946036493 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | ||||||||||
| UNIVERSITY OF CALIFORNIA SAN FRANC | 513 PARNASSUS AVENUE | 513 PARNASSUS AVENUE | SAN FRANCISCO | CA | 94102 | 946036493 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | ||||||||||
| UNIVERSITY OF CALIFORNIA SAN FRANC | 513 PARNASSUS AVENUE | 513 PARNASSUS AVENUE | SAN FRANCISCO | CA | 94102 | 946036493 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | ||||||||||
| UNIVERSITY OF CALIFORNIA SAN FRANC | 513 PARNASSUS AVENUE | 513 PARNASSUS AVENUE | SAN FRANCISCO | CA | 94102 | 946036493 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | ||||||||||
| UNIVERSITY OF CALIFORNIA SAN FRANC | 513 PARNASSUS AVENUE | 513 PARNASSUS AVENUE | SAN FRANCISCO | CA | 94102 | 946036493 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | ||||||||||
| UNIVERSITY OF CALIFORNIA SAN FRANC | 513 PARNASSUS AVENUE | 513 PARNASSUS AVENUE | SAN FRANCISCO | CA | 94102 | 946036493 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | ||||||||||
| UNIVERSITY OF CALIFORNIA SAN FRANC | 513 PARNASSUS AVENUE | 513 PARNASSUS AVENUE | SAN FRANCISCO | CA | 94102 | 946036493 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | ||||||||||
| UNIVERSITY OF CALIFORNIA SAN FRANC | 513 PARNASSUS AVENUE | 513 PARNASSUS AVENUE | SAN FRANCISCO | CA | 94102 | 946036493 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | ||||||||||
| UNIVERSITY OF CALIFORNIA SAN FRANC | 513 PARNASSUS AVENUE | 513 PARNASSUS AVENUE | SAN FRANCISCO | CA | 94102 | 946036493 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | ||||||||||
| UNIVERSITY OF CALIFORNIA SAN FRANC | 513 PARNASSUS AVENUE | 513 PARNASSUS AVENUE | SAN FRANCISCO | CA | 94102 | 946036493 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | ||||||||||
| UNIVERSITY OF CALIFORNIA SAN FRANC | 513 PARNASSUS AVENUE | 513 PARNASSUS AVENUE | SAN FRANCISCO | CA | 94102 | 946036493 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| LELAND STANFORD JUNIOR UNIVERSITY ( | ||||||||||
| LELAND STANFORD JUNIOR UNIVERSITY ( | 279 CAMPUS DRIVE WEST | 279 CAMPUS DRIVE WEST | STANFORD | CA | 94305 | 941156365 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| STANFORD UNIVERSITY | ||||||||||
| STANFORD UNIVERSITY | 1255269 CAMPUS DRIVE | 1255269 CAMPUS DRIVE | STANFORD | CA | 94305 | 941156365 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| STANFORD UNIVERSITY | ||||||||||
| STANFORD UNIVERSITY | 1255269 CAMPUS DRIVE | 1255269 CAMPUS DRIVE | STANFORD | CA | 94305 | 941156365 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| STANFORD UNIVERSITY | ||||||||||
| STANFORD UNIVERSITY | 1255269 CAMPUS DRIVE | 1255269 CAMPUS DRIVE | STANFORD | CA | 94305 | 941156365 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| STANFORD UNIVERSITY | ||||||||||
| STANFORD UNIVERSITY | 1255269 CAMPUS DRIVE | 1255269 CAMPUS DRIVE | STANFORD | CA | 94305 | 941156365 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| STANFORD UNIVERSITY | ||||||||||
| STANFORD UNIVERSITY | 1255269 CAMPUS DRIVE | 1255269 CAMPUS DRIVE | STANFORD | CA | 94305 | 941156365 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| STANFORD UNIVERSITY | ||||||||||
| STANFORD UNIVERSITY | 1255269 CAMPUS DRIVE | 1255269 CAMPUS DRIVE | STANFORD | CA | 94305 | 941156365 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| STANFORD UNIVERSITY | ||||||||||
| STANFORD UNIVERSITY | 1255269 CAMPUS DRIVE | 1255269 CAMPUS DRIVE | STANFORD | CA | 94305 | 941156365 | 3 | 1250000 | ACCRUAL | RESEARCH GRANT |
| STANFORD UNIVERSITY | ||||||||||
| STANFORD UNIVERSITY | 1255269 CAMPUS DRIVE | 1255269 CAMPUS DRIVE | STANFORD | CA | 94305 | 941156365 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| STANFORD UNIVERSITY | ||||||||||
| STANFORD UNIVERSITY | 1255269 CAMPUS DRIVE | 1255269 CAMPUS DRIVE | STANFORD | CA | 94305 | 941156365 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| STANFORD UNIVERSITY | ||||||||||
| STANFORD UNIVERSITY | 1255269 CAMPUS DRIVE | 1255269 CAMPUS DRIVE | STANFORD | CA | 94305 | 941156365 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF COLORADO | ||||||||||
| UNIVERSITY OF COLORADO | 6511 PO BOX | 6511 PO BOX | AURORA | CO | 80045 | 846000555 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF COLORADO | ||||||||||
| UNIVERSITY OF COLORADO | 6511 PO BOX | 6511 PO BOX | AURORA | CO | 80045 | 846000555 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF COLORADO HEALTH SCIEN | ||||||||||
| UNIVERSITY OF COLORADO HEALTH SCIEN | 6508 PO BOX | 6508 PO BOX | AURORA | CO | 80045 | 846000555 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF COLORADO | ||||||||||
| UNIVERSITY OF COLORADO | 6508 PO BOX | 6508 PO BOX | AURORA | CO | 80045 | 846000555 | 3 | 95137 | FMV | THERAPY ACCELERATION |
| YALE UNIVERSITY | ||||||||||
| YALE UNIVERSITY | 208250 PO BOX | 208250 PO BOX | NEW HAVEN | CT | 06510 | 060646973 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| YALE UNIVERSITY | ||||||||||
| YALE UNIVERSITY | 208250 PO BOX | 208250 PO BOX | NEW HAVEN | CT | 06510 | 060646973 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| YALE UNIVERSITY | ||||||||||
| YALE UNIVERSITY | 208250 PO BOX | 208250 PO BOX | NEW HAVEN | CT | 06510 | 060646973 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| YALE UNIVERSITY | ||||||||||
| YALE UNIVERSITY | 208250 PO BOX | 208250 PO BOX | NEW HAVEN | CT | 06510 | 060646973 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| YALE UNIVERSITY | ||||||||||
| YALE UNIVERSITY | 208250 PO BOX | 208250 PO BOX | NEW HAVEN | CT | 06510 | 060646973 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF FLORIDA | ||||||||||
| UNIVERSITY OF FLORIDA | 113001 PO BOX | 113001 PO BOX | GAINESVILLE | FL | 32601 | 596002052 | 3 | 140638 | FMV | THERAPY ACCELERATION |
| EMORY UNIVERSITY | ||||||||||
| EMORY UNIVERSITY | 1599 CLIFTON ROAD NE | 1599 CLIFTON ROAD NE | ATLANTA | GA | 30303 | 580566256 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF IOWA | ||||||||||
| UNIVERSITY OF IOWA | 51 NEWTON RD | 51 NEWTON RD | IOWA CITY | IA | 52240 | 426004813 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| NORTHWESTERN UNIVERSITY - CHICAGO C | ||||||||||
| NORTHWESTERN UNIVERSITY - CHICAGO C | 303 EAST SUPERIOR STREET | 303 EAST SUPERIOR STREET | CHICAGO | IL | 60601 | 362656113 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| NORTHWESTERN UNIVERSITY - CHICAGO C | ||||||||||
| NORTHWESTERN UNIVERSITY - CHICAGO C | 303 EAST SUPERIOR STREET | 303 EAST SUPERIOR STREET | CHICAGO | IL | 60601 | 362656113 | 3 | 1250000 | ACCRUAL | RESEARCH GRANT |
| NORTHWESTERN UNIVERSITY - CHICAGO C | ||||||||||
| NORTHWESTERN UNIVERSITY - CHICAGO C | 303 EAST SUPERIOR STREET | 303 EAST SUPERIOR STREET | CHICAGO | IL | 60601 | 362656113 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| NORTHWESTERN UNIVERSITY - CHICAGO C | ||||||||||
| NORTHWESTERN UNIVERSITY - CHICAGO C | 303 EAST SUPERIOR STREET | 303 EAST SUPERIOR STREET | CHICAGO | IL | 60601 | 362656113 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| THE UNIVERSITY OF CHICAGO | ||||||||||
| THE UNIVERSITY OF CHICAGO | 900 EAST 57TH STREET | 900 EAST 57TH STREET | CHICAGO | IL | 60601 | 3 | 55000 | ACCRUAL | RESEARCH GRANT | |
| THE UNIVERSITY OF CHICAGO | ||||||||||
| THE UNIVERSITY OF CHICAGO | 900 EAST 57TH STREET | 900 EAST 57TH STREET | CHICAGO | IL | 60601 | 3 | 55000 | ACCRUAL | RESEARCH GRANT | |
| THE UNIVERSITY OF CHICAGO | ||||||||||
| THE UNIVERSITY OF CHICAGO | 900 EAST 57TH STREET | 900 EAST 57TH STREET | CHICAGO | IL | 60601 | 3 | 110000 | ACCRUAL | RESEARCH GRANT | |
| THE UNIVERSITY OF CHICAGO | ||||||||||
| THE UNIVERSITY OF CHICAGO | 900 EAST 57TH STREET | 900 EAST 57TH STREET | CHICAGO | IL | 60601 | 3 | 65000 | ACCRUAL | RESEARCH GRANT | |
| UNIVERSITY OF ILLINOIS | ||||||||||
| UNIVERSITY OF ILLINOIS | 809 S MARSHFIELD | 809 S MARSHFIELD | CHICAGO | IL | 60601 | 376000511 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| BECKLOFF ASSOCIATES INC | ||||||||||
| BECKLOFF ASSOCIATES INC | 3203 SOLUTIONS CENTER | 3203 SOLUTIONS CENTER | CHICAGO | IL | 60601 | 480842223 | 265777 | FMV | THERAPY ACCELERATION | |
| INDIANA UNIVERSITY (INDIANAPOLIS) | ||||||||||
| INDIANA UNIVERSITY (INDIANAPOLIS) | 1044 W WALNUT STREET | 1044 W WALNUT STREET | INDIANAPOLIS | IN | 46201 | 356018940 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| BIOTECHNOLOGY INNOVATION & OPTIMIZA | ||||||||||
| BIOTECHNOLOGY INNOVATION & OPTIMIZA | 2097 CONSTANT AVE | 2097 CONSTANT AVE | LAWRENCE | KS | 66044 | 481124839 | 3 | 160841 | FMV | THERAPY ACCELERATION |
| BETH ISRAEL DEACONESS MEDICAL CENTE | ||||||||||
| BETH ISRAEL DEACONESS MEDICAL CENTE | 330 BROOKLINE AVENUE | 330 BROOKLINE AVENUE | BOSTON | MA | 02108 | 042103881 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| BETH ISRAEL DEACONESS MEDICAL CENTE | ||||||||||
| BETH ISRAEL DEACONESS MEDICAL CENTE | 330 BROOKLINE AVENUE | 330 BROOKLINE AVENUE | BOSTON | MA | 02108 | 042103881 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| BRIGHAM & WOMENS HOSPITAL | ||||||||||
| BRIGHAM & WOMENS HOSPITAL | 75 FRANCIS ST | 75 FRANCIS ST | BOSTON | MA | 02108 | 042312909 | 3 | 1250000 | ACCRUAL | RESEARCH GRANT |
| BRIGHAM & WOMENS HOSPITAL | ||||||||||
| BRIGHAM & WOMENS HOSPITAL | 75 FRANCIS ST | 75 FRANCIS ST | BOSTON | MA | 02108 | 042312909 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| BRIGHAM & WOMENS HOSPITAL | ||||||||||
| BRIGHAM & WOMENS HOSPITAL | 75 FRANCIS ST | 75 FRANCIS ST | BOSTON | MA | 02108 | 042312909 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| BRIGHAM & WOMENS HOSPITAL | ||||||||||
| BRIGHAM & WOMENS HOSPITAL | 75 FRANCIS ST | 75 FRANCIS ST | BOSTON | MA | 02108 | 042312909 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| CHILDREN'S HOSPITAL BOSTON | ||||||||||
| CHILDREN'S HOSPITAL BOSTON | 300 LONGWOOD AVENUE | 300 LONGWOOD AVENUE | BOSTON | MA | 02108 | 042774441 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | ||||||||||
| DANA FARBER CANCER INSTITUTE | 44 BINNEY STREET | 44 BINNEY STREET | BOSTON | MA | 02108 | 042263040 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | ||||||||||
| DANA FARBER CANCER INSTITUTE | 44 BINNEY STREET | 44 BINNEY STREET | BOSTON | MA | 02108 | 042263040 | 3 | 100000 | ACCRUAL | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | ||||||||||
| DANA FARBER CANCER INSTITUTE | 44 BINNEY STREET | 44 BINNEY STREET | BOSTON | MA | 02108 | 042263040 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | ||||||||||
| DANA FARBER CANCER INSTITUTE | 44 BINNEY STREET | 44 BINNEY STREET | BOSTON | MA | 02108 | 042263040 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | ||||||||||
| DANA FARBER CANCER INSTITUTE | 44 BINNEY STREET | 44 BINNEY STREET | BOSTON | MA | 02108 | 042263040 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | ||||||||||
| DANA FARBER CANCER INSTITUTE | 44 BINNEY STREET | 44 BINNEY STREET | BOSTON | MA | 02108 | 042263040 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | ||||||||||
| DANA FARBER CANCER INSTITUTE | 44 BINNEY STREET | 44 BINNEY STREET | BOSTON | MA | 02108 | 042263040 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| DANA-FARBER CANCER INSTITUTE | ||||||||||
| DANA-FARBER CANCER INSTITUTE | 44 BINNEY STREET | 44 BINNEY STREET | BOSTON | MA | 02108 | 042263040 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| DANA-FARBER CANCER INSTITUTE | ||||||||||
| DANA-FARBER CANCER INSTITUTE | 44 BINNEY STREET | 44 BINNEY STREET | BOSTON | MA | 02108 | 042263040 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| DANA-FARBER CANCER INSTITUTE | ||||||||||
| DANA-FARBER CANCER INSTITUTE | 44 BINNEY STREET | 44 BINNEY STREET | BOSTON | MA | 02108 | 042263040 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| DANA-FARBER CANCER INSTITUTE | ||||||||||
| DANA-FARBER CANCER INSTITUTE | 44 BINNEY STREET | 44 BINNEY STREET | BOSTON | MA | 02108 | 042263040 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| DANA-FARBER CANCER INSTITUTE | ||||||||||
| DANA-FARBER CANCER INSTITUTE | 44 BINNEY STREET | 44 BINNEY STREET | BOSTON | MA | 02108 | 042263040 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| DANA-FARBER CANCER INSTITUTE | ||||||||||
| DANA-FARBER CANCER INSTITUTE | 44 BINNEY STREET | 44 BINNEY STREET | BOSTON | MA | 02108 | 042263040 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| HARVARD MEDICAL SCHOOL | ||||||||||
| HARVARD MEDICAL SCHOOL | 1 BLACKFAN CIRCLE | 1 BLACKFAN CIRCLE | BOSTON | MA | 02108 | 530199180 | 3 | 1250000 | ACCRUAL | RESEARCH GRANT |
| HARVARD MEDICAL SCHOOL | ||||||||||
| HARVARD MEDICAL SCHOOL | 1 BLACKFAN CIRCLE | 1 BLACKFAN CIRCLE | BOSTON | MA | 02108 | 530199180 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| HARVARD MEDICAL SCHOOL | ||||||||||
| HARVARD MEDICAL SCHOOL | 1 BLACKFAN CIRCLE | 1 BLACKFAN CIRCLE | BOSTON | MA | 02108 | 530199180 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| HARVARD UNIVERSITY SCHOOL OF PUBLIC | ||||||||||
| HARVARD UNIVERSITY SCHOOL OF PUBLIC | 651 HUNTINGTON AVENUE | 651 HUNTINGTON AVENUE | BOSTON | MA | 02108 | 530199180 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| IMMUNE DISEASE INSTITUTE INC | ||||||||||
| IMMUNE DISEASE INSTITUTE INC | 3 BLACKFAN CIRCLE | 3 BLACKFAN CIRCLE | BOSTON | MA | 02108 | 042158520 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| IMMUNE DISEASE INSTITUTE INC | ||||||||||
| IMMUNE DISEASE INSTITUTE INC | 3 BLACKFAN CIRCLE | 3 BLACKFAN CIRCLE | BOSTON | MA | 02108 | 042158520 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| IMMUNE DISEASE INSTITUTE INC | ||||||||||
| IMMUNE DISEASE INSTITUTE INC | 3 BLACKFAN CIRCLE | 3 BLACKFAN CIRCLE | BOSTON | MA | 02108 | 042158520 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| MASSACHUSETTS GENERAL HOSPITAL (THE | ||||||||||
| MASSACHUSETTS GENERAL HOSPITAL (THE | 50 STANIFORD STREET | 50 STANIFORD STREET | BOSTON | MA | 02108 | 041564655 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| MASSACHUSETTS GENERAL HOSPITAL (THE | ||||||||||
| MASSACHUSETTS GENERAL HOSPITAL (THE | 50 STANIFORD STREET | 50 STANIFORD STREET | BOSTON | MA | 02108 | 041564655 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| MASSACHUSETTS GENERAL HOSPITAL (THE | ||||||||||
| MASSACHUSETTS GENERAL HOSPITAL (THE | 50 STANIFORD STREET | 50 STANIFORD STREET | BOSTON | MA | 02108 | 041564655 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| MASSACHUSETTS GENERAL HOSPITAL (THE | ||||||||||
| MASSACHUSETTS GENERAL HOSPITAL (THE | 50 STANIFORD STREET | 50 STANIFORD STREET | BOSTON | MA | 02108 | 041564655 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| MASSACHUSETTS GENERAL HOSPITAL (THE | ||||||||||
| MASSACHUSETTS GENERAL HOSPITAL (THE | 50 STANIFORD STREET | 50 STANIFORD STREET | BOSTON | MA | 02108 | 041564655 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| MASSACHUSETTS GENERAL HOSPITAL (THE | ||||||||||
| MASSACHUSETTS GENERAL HOSPITAL (THE | 50 STANIFORD STREET | 50 STANIFORD STREET | BOSTON | MA | 02108 | 041564655 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| ACETYLON PHARMACEUTICALS | ||||||||||
| ACETYLON PHARMACEUTICALS | 70 FARGO STREET | 70 FARGO STREET | BOSTON | MA | 02108 | 263506788 | 1500000 | FMV | THERAPY ACCELERATION | |
| CHILDRENS HOSPITAL OF BOSTON | ||||||||||
| CHILDRENS HOSPITAL OF BOSTON | 414413 PO BOX | 414413 PO BOX | BOSTON | MA | 02108 | 042774441 | 3 | 25000 | FMV | THERAPY ACCELERATION |
| MASSACHUSETTS INSTITUTE OF TECHNOLO | ||||||||||
| MASSACHUSETTS INSTITUTE OF TECHNOLO | 77 MASSACHUSETTS AVENUE | 77 MASSACHUSETTS AVENUE | CAMBRIDGE | MA | 02138 | 042103594 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| MASSACHUSETTS INSTITUTE OF TECHNOLO | ||||||||||
| MASSACHUSETTS INSTITUTE OF TECHNOLO | 77 MASSACHUSETTS AVENUE | 77 MASSACHUSETTS AVENUE | CAMBRIDGE | MA | 02138 | 042103594 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| WHITEHEAD INSTITUTE FOR BIOMEDICAL | ||||||||||
| WHITEHEAD INSTITUTE FOR BIOMEDICAL | 9 CAMBRIDGE CENTER | 9 CAMBRIDGE CENTER | CAMBRIDGE | MA | 02138 | 061043412 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| SHAPE | ||||||||||
| SHAPE | 55 CAMBRIDGE PARKWAY | 55 CAMBRIDGE PARKWAY | CAMBRIDGE | MA | 02138 | 263714475 | 1254000 | FMV | THERAPY ACCELERATION | |
| EPIZYME INC | ||||||||||
| EPIZYME INC | 325 VASSAR STREET | 325 VASSAR STREET | CAMBRIDGE | MA | 02138 | 261349956 | 1116000 | FMV | THERAPY ACCELERATION | |
| FORMA THERAPEUTICS | ||||||||||
| FORMA THERAPEUTICS | 790 MEMORIAL DRIVE | 790 MEMORIAL DRIVE | CAMBRIDGE | MA | 02138 | 260428600 | 600000 | FMV | THERAPY ACCELERATION | |
| BRANDEIS UNIVERSITY | ||||||||||
| BRANDEIS UNIVERSITY | 415 SOUTH STREET | 415 SOUTH STREET | WALTHAM | MA | 02543 | 042103552 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| AVILA | ||||||||||
| AVILA | 100 BEAVER STREET | 100 BEAVER STREET | WALTHAM | MA | 02543 | 204599701 | 1521562 | FMV | THERAPY ACCELERATION | |
| UNIVERSITY OF MASSACHUSETTS MEDICAL | ||||||||||
| UNIVERSITY OF MASSACHUSETTS MEDICAL | 364 PLANTATION STREET | 364 PLANTATION STREET | WORCESTER | MA | 01605 | 043167352 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MASSACHUSETTS MEDICAL | ||||||||||
| UNIVERSITY OF MASSACHUSETTS MEDICAL | 364 PLANTATION STREET | 364 PLANTATION STREET | WORCESTER | MA | 01605 | 043167352 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MASSACHUSETTS MEDICAL | ||||||||||
| UNIVERSITY OF MASSACHUSETTS MEDICAL | 364 PLANTATION STREET | 364 PLANTATION STREET | WORCESTER | MA | 01605 | 043167352 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MASSACHUSETTS MEDICAL | ||||||||||
| UNIVERSITY OF MASSACHUSETTS MEDICAL | 364 PLANTATION STREET | 364 PLANTATION STREET | WORCESTER | MA | 01605 | 043167352 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY | ||||||||||
| JOHNS HOPKINS UNIVERSITY | 1101 EAST 33RD STREET | 1101 EAST 33RD STREET | BALTIMORE | MD | 21201 | 520595110 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY | ||||||||||
| JOHNS HOPKINS UNIVERSITY | 1101 EAST 33RD STREET | 1101 EAST 33RD STREET | BALTIMORE | MD | 21201 | 520595110 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY | ||||||||||
| JOHNS HOPKINS UNIVERSITY | 1101 EAST 33RD STREET | 1101 EAST 33RD STREET | BALTIMORE | MD | 21201 | 520595110 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY | ||||||||||
| JOHNS HOPKINS UNIVERSITY | 1101 EAST 33RD STREET | 1101 EAST 33RD STREET | BALTIMORE | MD | 21201 | 520595110 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY | ||||||||||
| JOHNS HOPKINS UNIVERSITY | 1101 EAST 33RD STREET | 1101 EAST 33RD STREET | BALTIMORE | MD | 21201 | 520595110 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY | ||||||||||
| JOHNS HOPKINS UNIVERSITY | 1101 EAST 33RD STREET | 1101 EAST 33RD STREET | BALTIMORE | MD | 21201 | 520595110 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY | ||||||||||
| JOHNS HOPKINS UNIVERSITY | 1101 EAST 33RD STREET | 1101 EAST 33RD STREET | BALTIMORE | MD | 21201 | 520595110 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY SCHOOL OF | ||||||||||
| JOHNS HOPKINS UNIVERSITY SCHOOL OF | 725 NORTH WOLFE STREET | 725 NORTH WOLFE STREET | BALTIMORE | MD | 21201 | 520595110 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY SCHOOL OF | ||||||||||
| JOHNS HOPKINS UNIVERSITY SCHOOL OF | 725 NORTH WOLFE STREET | 725 NORTH WOLFE STREET | BALTIMORE | MD | 21201 | 520595110 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY SCHOOL OF | ||||||||||
| JOHNS HOPKINS UNIVERSITY SCHOOL OF | 725 NORTH WOLFE STREET | 725 NORTH WOLFE STREET | BALTIMORE | MD | 21201 | 520595110 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY SCHOOL OF | ||||||||||
| JOHNS HOPKINS UNIVERSITY SCHOOL OF | 725 NORTH WOLFE STREET | 725 NORTH WOLFE STREET | BALTIMORE | MD | 21201 | 520595110 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY SCHOOL OF | ||||||||||
| JOHNS HOPKINS UNIVERSITY SCHOOL OF | 725 NORTH WOLFE STREET | 725 NORTH WOLFE STREET | BALTIMORE | MD | 21201 | 520595110 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MARYLAND BALTIMORE | ||||||||||
| UNIVERSITY OF MARYLAND BALTIMORE | 655 WEST BALTIMORE STREET | 655 WEST BALTIMORE STREET | BALTIMORE | MD | 21201 | 526002033 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MARYLAND BALTIMORE | ||||||||||
| UNIVERSITY OF MARYLAND BALTIMORE | 655 WEST BALTIMORE STREET | 655 WEST BALTIMORE STREET | BALTIMORE | MD | 21201 | 526002033 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MICHIGAN | ||||||||||
| UNIVERSITY OF MICHIGAN | 1500 E MEDICAL CENTER DRIVE | 1500 E MEDICAL CENTER DRIVE | ANN ARBOR | MI | 48109 | 386006309 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MICHIGAN | ||||||||||
| UNIVERSITY OF MICHIGAN | 1500 E MEDICAL CENTER DRIVE | 1500 E MEDICAL CENTER DRIVE | ANN ARBOR | MI | 48109 | 386006309 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MICHIGAN | ||||||||||
| UNIVERSITY OF MICHIGAN | 1500 E MEDICAL CENTER DRIVE | 1500 E MEDICAL CENTER DRIVE | ANN ARBOR | MI | 48109 | 386006309 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MICHIGAN | ||||||||||
| UNIVERSITY OF MICHIGAN | 1500 E MEDICAL CENTER DRIVE | 1500 E MEDICAL CENTER DRIVE | ANN ARBOR | MI | 48109 | 386006309 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MICHIGAN | ||||||||||
| UNIVERSITY OF MICHIGAN | 1500 E MEDICAL CENTER DRIVE | 1500 E MEDICAL CENTER DRIVE | ANN ARBOR | MI | 48109 | 386006309 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MICHIGAN | ||||||||||
| UNIVERSITY OF MICHIGAN | 1500 E MEDICAL CENTER DRIVE | 1500 E MEDICAL CENTER DRIVE | ANN ARBOR | MI | 48109 | 386006309 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MICHIGAN | ||||||||||
| UNIVERSITY OF MICHIGAN | 1500 E MEDICAL CENTER DRIVE | 1500 E MEDICAL CENTER DRIVE | ANN ARBOR | MI | 48109 | 386006309 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MICHIGAN | ||||||||||
| UNIVERSITY OF MICHIGAN | 1500 E MEDICAL CENTER DRIVE | 1500 E MEDICAL CENTER DRIVE | ANN ARBOR | MI | 48109 | 386006309 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MICHIGAN | ||||||||||
| UNIVERSITY OF MICHIGAN | 1500 E MEDICAL CENTER DRIVE | 1500 E MEDICAL CENTER DRIVE | ANN ARBOR | MI | 48109 | 386006309 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MICHIGAN | ||||||||||
| UNIVERSITY OF MICHIGAN | 1500 E MEDICAL CENTER DRIVE | 1500 E MEDICAL CENTER DRIVE | ANN ARBOR | MI | 48109 | 386006309 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MINNESOTA | ||||||||||
| UNIVERSITY OF MINNESOTA | 450 MCNAMARA ALUMNI CENTER | 450 MCNAMARA ALUMNI CENTER | MINNEAPOLIS | MN | 55401 | 416007513 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MINNESOTA - TWIN CITI | ||||||||||
| UNIVERSITY OF MINNESOTA - TWIN CITI | 321 CHURCH STREET SE | 321 CHURCH STREET SE | MINNEAPOLIS | MN | 55401 | 416007513 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MINNESOTA - TWIN CITI | ||||||||||
| UNIVERSITY OF MINNESOTA - TWIN CITI | 321 CHURCH STREET SE | 321 CHURCH STREET SE | MINNEAPOLIS | MN | 55401 | 416007513 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MINNESOTA - TWIN CITI | ||||||||||
| UNIVERSITY OF MINNESOTA - TWIN CITI | 321 CHURCH STREET SE | 321 CHURCH STREET SE | MINNEAPOLIS | MN | 55401 | 416007513 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MINNESOTA TWIN CITIE | ||||||||||
| UNIVERSITY OF MINNESOTA TWIN CITIE | 321 CHURCH STREET SE | 321 CHURCH STREET SE | MINNEAPOLIS | MN | 55401 | 416007513 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| MAYO CLINIC & FOUNDATION | ||||||||||
| MAYO CLINIC & FOUNDATION | 200 FIRST STREET | 200 FIRST STREET | ROCHESTER | MN | 55901 | 411506440 | 3 | 100000 | ACCRUAL | RESEARCH GRANT |
| MAYO CLINIC & FOUNDATION | ||||||||||
| MAYO CLINIC & FOUNDATION | 200 FIRST STREET | 200 FIRST STREET | ROCHESTER | MN | 55901 | 411506440 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| MAYO CLINIC & FOUNDATION | ||||||||||
| MAYO CLINIC & FOUNDATION | 200 FIRST STREET | 200 FIRST STREET | ROCHESTER | MN | 55901 | 411506440 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| MAYO CLINIC & FOUNDATION | ||||||||||
| MAYO CLINIC & FOUNDATION | 200 FIRST STREET | 200 FIRST STREET | ROCHESTER | MN | 55901 | 411506440 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| MAYO CLINIC & FOUNDATION | ||||||||||
| MAYO CLINIC & FOUNDATION | 200 FIRST STREET | 200 FIRST STREET | ROCHESTER | MN | 55901 | 411506440 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| STOWERS INSTITUTE FOR MEDICAL RESEA | ||||||||||
| STOWERS INSTITUTE FOR MEDICAL RESEA | 1000 EAST 50TH STREET | 1000 EAST 50TH STREET | KANSAS CITY | MO | 64110 | 436384454 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| WASHINGTON UNIVERSITY IN ST LOUIS | ||||||||||
| WASHINGTON UNIVERSITY IN ST LOUIS | 660 S EUCLID AVE | 660 S EUCLID AVE | ST LOUIS | MO | 63110 | 430653611 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| WASHINGTON UNIVERSITY IN ST LOUIS | ||||||||||
| WASHINGTON UNIVERSITY IN ST LOUIS | 660 S EUCLID AVE | 660 S EUCLID AVE | ST LOUIS | MO | 63110 | 430653611 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| WASHINGTON UNIVERSITY IN ST LOUIS | ||||||||||
| WASHINGTON UNIVERSITY IN ST LOUIS | 660 S EUCLID AVE | 660 S EUCLID AVE | ST LOUIS | MO | 63110 | 430653611 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| WASHINGTON UNIVERSITY IN ST LOUIS | ||||||||||
| WASHINGTON UNIVERSITY IN ST LOUIS | 660 S EUCLID AVE | 660 S EUCLID AVE | ST LOUIS | MO | 63110 | 430653611 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF NORTH CAROLINA AT CHA | ||||||||||
| UNIVERSITY OF NORTH CAROLINA AT CHA | 101 MANNING DRIVE | 101 MANNING DRIVE | CHAPEL HILL | NC | 27514 | 566001393 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF NORTH CAROLINA AT CHA | ||||||||||
| UNIVERSITY OF NORTH CAROLINA AT CHA | 101 MANNING DRIVE | 101 MANNING DRIVE | CHAPEL HILL | NC | 27514 | 566001393 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF NORTH CAROLINA AT CHA | ||||||||||
| UNIVERSITY OF NORTH CAROLINA AT CHA | 101 MANNING DRIVE | 101 MANNING DRIVE | CHAPEL HILL | NC | 27514 | 566001393 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| DUKE UNIVERSITY | ||||||||||
| DUKE UNIVERSITY | 2200 WEST MAIN STREET | 2200 WEST MAIN STREET | DURHAM | NC | 27701 | 560532129 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| DUKE UNIVERSITY | ||||||||||
| DUKE UNIVERSITY | 2200 WEST MAIN STREET | 2200 WEST MAIN STREET | DURHAM | NC | 27701 | 560532129 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| DUKE UNIVERSITY | ||||||||||
| DUKE UNIVERSITY | 2200 WEST MAIN STREET | 2200 WEST MAIN STREET | DURHAM | NC | 27701 | 560532129 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| DUKE UNIVERSITY | ||||||||||
| DUKE UNIVERSITY | 2200 WEST MAIN STREET | 2200 WEST MAIN STREET | DURHAM | NC | 27701 | 560532129 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| DUKE UNIVERSITY | ||||||||||
| DUKE UNIVERSITY | 2200 WEST MAIN STREET | 2200 WEST MAIN STREET | DURHAM | NC | 27701 | 560532129 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UMDNJ--ROBERT WOOD JOHNSON MEDICAL | ||||||||||
| UMDNJ--ROBERT WOOD JOHNSON MEDICAL | 335 GEORGE STREET | 335 GEORGE STREET | NEW BRUNSWICK | NJ | 08901 | 221776306 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| CELATOR PHARMACEUTICALS | ||||||||||
| CELATOR PHARMACEUTICALS | 303B COLLEGE ROAD EAST | 303B COLLEGE ROAD EAST | PRINCETON | NJ | 08540 | 202680869 | 980000 | FMV | THERAPY ACCELERATION | |
| ALBERT EINSTEIN COLLEGE OF MEDICINE | ||||||||||
| ALBERT EINSTEIN COLLEGE OF MEDICINE | 1300 MORRIS PARK AVE | 1300 MORRIS PARK AVE | BRONX | NY | 10461 | 131624225 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| ALBERT EINSTEIN COLLEGE OF MEDICINE | ||||||||||
| ALBERT EINSTEIN COLLEGE OF MEDICINE | 1300 MORRIS PARK AVE | 1300 MORRIS PARK AVE | BRONX | NY | 10461 | 131624225 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| HEALTH RESEARCH INCORPORATED ROSWE | ||||||||||
| HEALTH RESEARCH INCORPORATED ROSWE | 1 ELM CARLTON STREETS | 1 ELM CARLTON STREETS | BUFFALO | NY | 14201 | 042158520 | 3 | 100000 | ACCRUAL | RESEARCH GRANT |
| HEALTH RESEARCH INCORPORATED ROSWE | ||||||||||
| HEALTH RESEARCH INCORPORATED ROSWE | 1 ELM CARLTON STREETS | 1 ELM CARLTON STREETS | BUFFALO | NY | 14201 | 042158520 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| BIOTHERYX | ||||||||||
| BIOTHERYX | 20 CABIN RIDGE ROAD | 20 CABIN RIDGE ROAD | CHAPPAQUA | NY | 10514 | 260201342 | 4500000 | FMV | THERAPY ACCELERATION | |
| COLD SPRING HARBOR LABORATORY | ||||||||||
| COLD SPRING HARBOR LABORATORY | 1 BUNGTOWN ROAD | 1 BUNGTOWN ROAD | COLD SPRING HARBOR | NY | 11724 | 111631792 | 3 | 1250000 | ACCRUAL | RESEARCH GRANT |
| COLUMBIA UNIVERSITY | ||||||||||
| COLUMBIA UNIVERSITY | 1150 ST NICHOLAS AVENUE | 1150 ST NICHOLAS AVENUE | NEW YORK | NY | 10001 | 135598093 | 3 | 1250000 | ACCRUAL | RESEARCH GRANT |
| COLUMBIA UNIVERSITY | ||||||||||
| COLUMBIA UNIVERSITY | 1150 ST NICHOLAS AVENUE | 1150 ST NICHOLAS AVENUE | NEW YORK | NY | 10001 | 135598093 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| COLUMBIA UNIVERSITY | ||||||||||
| COLUMBIA UNIVERSITY | 1150 ST NICHOLAS AVENUE | 1150 ST NICHOLAS AVENUE | NEW YORK | NY | 10001 | 135598093 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| COLUMBIA UNIVERSITY | ||||||||||
| COLUMBIA UNIVERSITY | 1150 ST NICHOLAS AVENUE | 1150 ST NICHOLAS AVENUE | NEW YORK | NY | 10001 | 135598093 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| COLUMBIA UNIVERSITY | ||||||||||
| COLUMBIA UNIVERSITY | 1150 ST NICHOLAS AVENUE | 1150 ST NICHOLAS AVENUE | NEW YORK | NY | 10001 | 135598093 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| COLUMBIA UNIVERSITY MEDICAL CENTER | ||||||||||
| COLUMBIA UNIVERSITY MEDICAL CENTER | 1150 ST NICHOLAS AVENUE | 1150 ST NICHOLAS AVENUE | NEW YORK | NY | 10001 | 135598093 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| COLUMBIA UNIVERSITY MEDICAL CENTER | ||||||||||
| COLUMBIA UNIVERSITY MEDICAL CENTER | 1150 ST NICHOLAS AVENUE | 1150 ST NICHOLAS AVENUE | NEW YORK | NY | 10001 | 135598093 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| COLUMBIA UNIVERSITY MEDICAL CENTER | ||||||||||
| COLUMBIA UNIVERSITY MEDICAL CENTER | 1150 ST NICHOLAS AVENUE | 1150 ST NICHOLAS AVENUE | NEW YORK | NY | 10001 | 135598093 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| COLUMBIA UNIVERSITY MEDICAL CENTER | ||||||||||
| COLUMBIA UNIVERSITY MEDICAL CENTER | 1150 ST NICHOLAS AVENUE | 1150 ST NICHOLAS AVENUE | NEW YORK | NY | 10001 | 135598093 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| CORNELL UNIVERSITY MEDICAL COLLEGE | ||||||||||
| CORNELL UNIVERSITY MEDICAL COLLEGE | 1300 YORK AVE | 1300 YORK AVE | NEW YORK | NY | 10001 | 133376695 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| CORNELL UNIVERSITY MEDICAL COLLEGE | ||||||||||
| CORNELL UNIVERSITY MEDICAL COLLEGE | 1300 YORK AVE | 1300 YORK AVE | NEW YORK | NY | 10001 | 133376695 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| CORNELL UNIVERSITY MEDICAL COLLEGE | ||||||||||
| CORNELL UNIVERSITY MEDICAL COLLEGE | 1300 YORK AVE | 1300 YORK AVE | NEW YORK | NY | 10001 | 133376695 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| CORNELL UNIVERSITY MEDICAL COLLEGE | ||||||||||
| CORNELL UNIVERSITY MEDICAL COLLEGE | 1300 YORK AVE | 1300 YORK AVE | NEW YORK | NY | 10001 | 133376695 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| JOAN & SANFORD I WEILL MEDICAL COL | ||||||||||
| JOAN & SANFORD I WEILL MEDICAL COL | 435 EAST 70TH STREET | 435 EAST 70TH STREET | NEW YORK | NY | 10001 | 133376695 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| JOAN & SANFORD I WEILL MEDICAL COL | ||||||||||
| JOAN & SANFORD I WEILL MEDICAL COL | 435 EAST 70TH STREET | 435 EAST 70TH STREET | NEW YORK | NY | 10001 | 133376695 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| MEMORIAL SLOAN KETTERING CANCER CEN | ||||||||||
| MEMORIAL SLOAN KETTERING CANCER CEN | 633 THIRD AVENUE | 633 THIRD AVENUE | NEW YORK | NY | 10001 | 912154267 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| MEMORIAL SLOAN-KETTERING CANCER CEN | ||||||||||
| MEMORIAL SLOAN-KETTERING CANCER CEN | 633 THIRD AVENUE | 633 THIRD AVENUE | NEW YORK | NY | 10001 | 912154267 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| MEMORIAL SLOAN-KETTERING CANCER CEN | ||||||||||
| MEMORIAL SLOAN-KETTERING CANCER CEN | 633 THIRD AVENUE | 633 THIRD AVENUE | NEW YORK | NY | 10001 | 912154267 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| MEMORIAL SLOAN-KETTERING CANCER CEN | ||||||||||
| MEMORIAL SLOAN-KETTERING CANCER CEN | 633 THIRD AVENUE | 633 THIRD AVENUE | NEW YORK | NY | 10001 | 912154267 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| MEMORIAL SLOAN-KETTERING CANCER CEN | ||||||||||
| MEMORIAL SLOAN-KETTERING CANCER CEN | 633 THIRD AVENUE | 633 THIRD AVENUE | NEW YORK | NY | 10001 | 912154267 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| MEMORIAL SLOAN-KETTERING CANCER CEN | ||||||||||
| MEMORIAL SLOAN-KETTERING CANCER CEN | 633 THIRD AVENUE | 633 THIRD AVENUE | NEW YORK | NY | 10001 | 912154267 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| MEMORIAL SLOAN-KETTERING CANCER CEN | ||||||||||
| MEMORIAL SLOAN-KETTERING CANCER CEN | 633 THIRD AVENUE | 633 THIRD AVENUE | NEW YORK | NY | 10001 | 912154267 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| NEW YORK UNIVERSITY SCHOOL OF MEDIC | ||||||||||
| NEW YORK UNIVERSITY SCHOOL OF MEDIC | 550 FIRST AVENUE | 550 FIRST AVENUE | NEW YORK | NY | 10001 | 136171197 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| NEW YORK UNIVERSITY SCHOOL OF MEDIC | ||||||||||
| NEW YORK UNIVERSITY SCHOOL OF MEDIC | 550 FIRST AVENUE | 550 FIRST AVENUE | NEW YORK | NY | 10001 | 136171197 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| NEW YORK UNIVERSITY SCHOOL OF MEDIC | ||||||||||
| NEW YORK UNIVERSITY SCHOOL OF MEDIC | 550 FIRST AVENUE | 550 FIRST AVENUE | NEW YORK | NY | 10001 | 136171197 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| NEW YORK UNIVERSITY SCHOOL OF MEDIC | ||||||||||
| NEW YORK UNIVERSITY SCHOOL OF MEDIC | 550 FIRST AVENUE | 550 FIRST AVENUE | NEW YORK | NY | 10001 | 136171197 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| NEW YORK UNIVERSITY SCHOOL OF MEDIC | ||||||||||
| NEW YORK UNIVERSITY SCHOOL OF MEDIC | 550 FIRST AVENUE | 550 FIRST AVENUE | NEW YORK | NY | 10001 | 136171197 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| NEW YORK UNIVERSITY SCHOOL OF MEDIC | ||||||||||
| NEW YORK UNIVERSITY SCHOOL OF MEDIC | 550 FIRST AVENUE | 550 FIRST AVENUE | NEW YORK | NY | 10001 | 136171197 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| NEW YORK UNIVERSITY SCHOOL OF MEDIC | ||||||||||
| NEW YORK UNIVERSITY SCHOOL OF MEDIC | 550 FIRST AVENUE | 550 FIRST AVENUE | NEW YORK | NY | 10001 | 136171197 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| ROCKEFELLER UNIVERSITY | ||||||||||
| ROCKEFELLER UNIVERSITY | 1230 YORK AVENUE | 1230 YORK AVENUE | NEW YORK | NY | 10001 | 131624158 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| WEILL MEDICAL COLLEGE OF CORNELL UN | ||||||||||
| WEILL MEDICAL COLLEGE OF CORNELL UN | 575 LEXINGTON AVENUE | 575 LEXINGTON AVENUE | NEW YORK | NY | 10001 | 133376695 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| ROCKEFELLER UNIVERSITY | ||||||||||
| ROCKEFELLER UNIVERSITY | 1230 YORK AVENUE | 1230 YORK AVENUE | NEW YORK | NY | 10001 | 131624158 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF ROCHESTER | ||||||||||
| UNIVERSITY OF ROCHESTER | 601 ELMWOOD AVENUE | 601 ELMWOOD AVENUE | ROCHESTER | NY | 14603 | 160473209 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF ROCHESTER | ||||||||||
| UNIVERSITY OF ROCHESTER | 601 ELMWOOD AVENUE | 601 ELMWOOD AVENUE | ROCHESTER | NY | 14603 | 160473209 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF ROCHESTER | ||||||||||
| UNIVERSITY OF ROCHESTER | 601 ELMWOOD AVENUE | 601 ELMWOOD AVENUE | ROCHESTER | NY | 14603 | 160473209 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF ROCHESTER | ||||||||||
| UNIVERSITY OF ROCHESTER | 601 ELMWOOD AVENUE | 601 ELMWOOD AVENUE | ROCHESTER | NY | 14603 | 160473209 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF ROCHESTER | ||||||||||
| UNIVERSITY OF ROCHESTER | 601 ELMWOOD AVENUE | 601 ELMWOOD AVENUE | ROCHESTER | NY | 14603 | 160473209 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| CHILDRENS HOSPITAL MEDICAL CENTER-C | ||||||||||
| CHILDRENS HOSPITAL MEDICAL CENTER-C | 7013 3333 BURNET AVENUE | 7013 3333 BURNET AVENUE | CINCINNATI | OH | 45202 | 310833936 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| CHILDRENS HOSPITAL MEDICAL CENTER-C | ||||||||||
| CHILDRENS HOSPITAL MEDICAL CENTER-C | 7013 3333 BURNET AVENUE | 7013 3333 BURNET AVENUE | CINCINNATI | OH | 45202 | 310833936 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF CINCINNATI | ||||||||||
| UNIVERSITY OF CINCINNATI | 231 ALBERT SABIN WAY | 231 ALBERT SABIN WAY | CINCINNATI | OH | 45202 | 316000989 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| CLEVELAND CLINIC | ||||||||||
| CLEVELAND CLINIC | 931568 PO BOX | 931568 PO BOX | CLEVELAND | OH | 44149 | 340714585 | 3 | 590000 | FMV | THERAPY ACCELERATION |
| OHIO STATE UNIVERSITY | ||||||||||
| OHIO STATE UNIVERSITY | 1960 KENNY ROAD | 1960 KENNY ROAD | COLUMBUS | OH | 43085 | 316401599 | 3 | 1250000 | ACCRUAL | RESEARCH GRANT |
| OHIO STATE UNIVERSITY | ||||||||||
| OHIO STATE UNIVERSITY | 1960 KENNY ROAD | 1960 KENNY ROAD | COLUMBUS | OH | 43085 | 316401599 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| OHIO STATE UNIVERSITY | ||||||||||
| OHIO STATE UNIVERSITY | 1960 KENNY ROAD | 1960 KENNY ROAD | COLUMBUS | OH | 43085 | 316401599 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| OHIO STATE UNIVERSITY | ||||||||||
| OHIO STATE UNIVERSITY | 1960 KENNY ROAD | 1960 KENNY ROAD | COLUMBUS | OH | 43085 | 316401599 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| OREGON HEALTH & SCIENCE UNIVERSITY | ||||||||||
| OREGON HEALTH & SCIENCE UNIVERSITY | 3181 SW SAM JACKSON PARK RD | 3181 SW SAM JACKSON PARK RD | PORTLAND | OR | 97239 | 237083114 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| OREGON HEALTH & SCIENCE UNIVERSITY | ||||||||||
| OREGON HEALTH & SCIENCE UNIVERSITY | 3181 SW SAM JACKSON PARK RD | 3181 SW SAM JACKSON PARK RD | PORTLAND | OR | 97239 | 237083114 | 3 | 1250000 | ACCRUAL | RESEARCH GRANT |
| OREGON HEALTH & SCIENCE UNIVERSITY | ||||||||||
| OREGON HEALTH & SCIENCE UNIVERSITY | 3181 SW SAM JACKSON PARK RD | 3181 SW SAM JACKSON PARK RD | PORTLAND | OR | 97239 | 237083114 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| ASCENTA THERAPEUTICS | ||||||||||
| ASCENTA THERAPEUTICS | 101 LINDENWOOD DRIVE | 101 LINDENWOOD DRIVE | MALVERN | PA | 19355 | 562394460 | 1150007 | FMV | THERAPY ACCELERATION | |
| ONCONOVA | ||||||||||
| ONCONOVA | 375 PHEASANT RUN | 375 PHEASANT RUN | NEWTOWN | PA | 18940 | 223627252 | 1900000 | FMV | THERAPY ACCELERATION | |
| CHILDRENS HOSPITAL OF PHILADELPHIA | ||||||||||
| CHILDRENS HOSPITAL OF PHILADELPHIA | 3615 CIVIC CENTER BOULEVARD | 3615 CIVIC CENTER BOULEVARD | PHILADELPHIA | PA | 19102 | 231352166 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| DREXEL UNIVERSITY | ||||||||||
| DREXEL UNIVERSITY | 497 245 N 15TH STREET | 497 245 N 15TH STREET | PHILADELPHIA | PA | 19102 | 231352630 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | ||||||||||
| UNIVERSITY OF PENNSYLVANIA | 3451 WALNUT STREET | 3451 WALNUT STREET | PHILADELPHIA | PA | 19102 | 231352685 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | ||||||||||
| UNIVERSITY OF PENNSYLVANIA | 3451 WALNUT STREET | 3451 WALNUT STREET | PHILADELPHIA | PA | 19102 | 231352685 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | ||||||||||
| UNIVERSITY OF PENNSYLVANIA | 3451 WALNUT STREET | 3451 WALNUT STREET | PHILADELPHIA | PA | 19102 | 231352685 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | ||||||||||
| UNIVERSITY OF PENNSYLVANIA | 3451 WALNUT STREET | 3451 WALNUT STREET | PHILADELPHIA | PA | 19102 | 231352685 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | ||||||||||
| UNIVERSITY OF PENNSYLVANIA | 3451 WALNUT STREET | 3451 WALNUT STREET | PHILADELPHIA | PA | 19102 | 231352685 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | ||||||||||
| UNIVERSITY OF PENNSYLVANIA | 3451 WALNUT STREET | 3451 WALNUT STREET | PHILADELPHIA | PA | 19102 | 231352685 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | ||||||||||
| UNIVERSITY OF PENNSYLVANIA | 3451 WALNUT STREET | 3451 WALNUT STREET | PHILADELPHIA | PA | 19102 | 231352685 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | ||||||||||
| UNIVERSITY OF PENNSYLVANIA | 3451 WALNUT STREET | 3451 WALNUT STREET | PHILADELPHIA | PA | 19102 | 231352685 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | ||||||||||
| UNIVERSITY OF PENNSYLVANIA | 3451 WALNUT STREET | 3451 WALNUT STREET | PHILADELPHIA | PA | 19102 | 231352685 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF PITTSBURGH | ||||||||||
| UNIVERSITY OF PITTSBURGH | 5117 CENTER AVE | 5117 CENTER AVE | PITTSBURGH | PA | 15213 | 250965591 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF PITTSBURGH | ||||||||||
| UNIVERSITY OF PITTSBURGH | 5117 CENTER AVE | 5117 CENTER AVE | PITTSBURGH | PA | 15213 | 250965591 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF PITTSBURGH | ||||||||||
| UNIVERSITY OF PITTSBURGH | 5117 CENTER AVE | 5117 CENTER AVE | PITTSBURGH | PA | 15213 | 250965591 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF MICHIGAN | ||||||||||
| UNIVERSITY OF MICHIGAN | 223131 PO BOX | 223131 PO BOX | PITTSBURGH | PA | 15213 | 386006309 | 3 | 41800 | FMV | THERAPY ACCELERATION |
| VANDERBILT UNIVERSITY MEDICAL CENTE | ||||||||||
| VANDERBILT UNIVERSITY MEDICAL CENTE | 2220 PIERCE AVE | 2220 PIERCE AVE | NASHVILLE | TN | 37201 | 620476822 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| MEMGEN | ||||||||||
| MEMGEN | 7557 RAMBLER ROAD | 7557 RAMBLER ROAD | DALLAS | TX | 75201 | 352232976 | 810795 | FMV | THERAPY ACCELERATION | |
| BAYLOR COLLEGE OF MEDICINE | ||||||||||
| BAYLOR COLLEGE OF MEDICINE | 1 BAYLOR PLAZA | 1 BAYLOR PLAZA | HOUSTON | TX | 77002 | 741613878 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| BAYLOR COLLEGE OF MEDICINE | ||||||||||
| BAYLOR COLLEGE OF MEDICINE | 1 BAYLOR PLAZA | 1 BAYLOR PLAZA | HOUSTON | TX | 77002 | 741613878 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| BAYLOR COLLEGE OF MEDICINE | ||||||||||
| BAYLOR COLLEGE OF MEDICINE | 1 BAYLOR PLAZA | 1 BAYLOR PLAZA | HOUSTON | TX | 77002 | 741613878 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| BAYLOR COLLEGE OF MEDICINE | ||||||||||
| BAYLOR COLLEGE OF MEDICINE | 1 BAYLOR PLAZA | 1 BAYLOR PLAZA | HOUSTON | TX | 77002 | 741613878 | 3 | 1250000 | ACCRUAL | RESEARCH GRANT |
| BAYLOR COLLEGE OF MEDICINE | ||||||||||
| BAYLOR COLLEGE OF MEDICINE | 1 BAYLOR PLAZA | 1 BAYLOR PLAZA | HOUSTON | TX | 77002 | 741613878 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| BAYLOR COLLEGE OF MEDICINE | ||||||||||
| BAYLOR COLLEGE OF MEDICINE | 1 BAYLOR PLAZA | 1 BAYLOR PLAZA | HOUSTON | TX | 77002 | 741613878 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | ||||||||||
| UNIVERSITY OF TEXAS | 1515 HOLCOMBE BLVD UNIT 202 | 1515 HOLCOMBE BLVD UNIT 202 | HOUSTON | TX | 77002 | 760300816 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | ||||||||||
| UNIVERSITY OF TEXAS | 1515 HOLCOMBE BLVD UNIT 202 | 1515 HOLCOMBE BLVD UNIT 202 | HOUSTON | TX | 77002 | 760300816 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | ||||||||||
| UNIVERSITY OF TEXAS | 1515 HOLCOMBE BLVD UNIT 202 | 1515 HOLCOMBE BLVD UNIT 202 | HOUSTON | TX | 77002 | 760300816 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | ||||||||||
| UNIVERSITY OF TEXAS | 1515 HOLCOMBE BLVD UNIT 202 | 1515 HOLCOMBE BLVD UNIT 202 | HOUSTON | TX | 77002 | 760300816 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | ||||||||||
| UNIVERSITY OF TEXAS | 1515 HOLCOMBE BLVD UNIT 202 | 1515 HOLCOMBE BLVD UNIT 202 | HOUSTON | TX | 77002 | 760300816 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | ||||||||||
| UNIVERSITY OF TEXAS | 1515 HOLCOMBE BLVD UNIT 202 | 1515 HOLCOMBE BLVD UNIT 202 | HOUSTON | TX | 77002 | 760300816 | 3 | 1250000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | ||||||||||
| UNIVERSITY OF TEXAS | 1515 HOLCOMBE BLVD UNIT 202 | 1515 HOLCOMBE BLVD UNIT 202 | HOUSTON | TX | 77002 | 760300816 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | ||||||||||
| UNIVERSITY OF TEXAS | 1515 HOLCOMBE BLVD UNIT 202 | 1515 HOLCOMBE BLVD UNIT 202 | HOUSTON | TX | 77002 | 760300816 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | ||||||||||
| UNIVERSITY OF TEXAS | 1515 HOLCOMBE BLVD UNIT 202 | 1515 HOLCOMBE BLVD UNIT 202 | HOUSTON | TX | 77002 | 760300816 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | ||||||||||
| UNIVERSITY OF TEXAS | 1515 HOLCOMBE BLVD UNIT 202 | 1515 HOLCOMBE BLVD UNIT 202 | HOUSTON | TX | 77002 | 760300816 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | ||||||||||
| UNIVERSITY OF TEXAS | 1515 HOLCOMBE BLVD UNIT 202 | 1515 HOLCOMBE BLVD UNIT 202 | HOUSTON | TX | 77002 | 760300816 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | ||||||||||
| UNIVERSITY OF TEXAS | 1515 HOLCOMBE BLVD UNIT 202 | 1515 HOLCOMBE BLVD UNIT 202 | HOUSTON | TX | 77002 | 760300816 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | ||||||||||
| UNIVERSITY OF TEXAS | 1515 HOLCOMBE BLVD UNIT 202 | 1515 HOLCOMBE BLVD UNIT 202 | HOUSTON | TX | 77002 | 760300816 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | ||||||||||
| UNIVERSITY OF TEXAS | 1515 HOLCOMBE BLVD UNIT 202 | 1515 HOLCOMBE BLVD UNIT 202 | HOUSTON | TX | 77002 | 760300816 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | ||||||||||
| UNIVERSITY OF TEXAS | 1515 HOLCOMBE BLVD UNIT 202 | 1515 HOLCOMBE BLVD UNIT 202 | HOUSTON | TX | 77002 | 760300816 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF TEXAS SAN ANTONIO | ||||||||||
| UNIVERSITY OF TEXAS SAN ANTONIO | 7703 FLOYD CURL DRIVE | 7703 FLOYD CURL DRIVE | SAN ANTONIO | TX | 78229 | 741717115 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF UTAH | ||||||||||
| UNIVERSITY OF UTAH | 2000 CIRCLE OF HOPE | 2000 CIRCLE OF HOPE | SALT LAKE CITY | UT | 84112 | 876000525 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF UTAH | ||||||||||
| UNIVERSITY OF UTAH | 2000 CIRCLE OF HOPE | 2000 CIRCLE OF HOPE | SALT LAKE CITY | UT | 84112 | 876000525 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF UTAH | ||||||||||
| UNIVERSITY OF UTAH | 2000 CIRCLE OF HOPE | 2000 CIRCLE OF HOPE | SALT LAKE CITY | UT | 84112 | 876000525 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF UTAH | ||||||||||
| UNIVERSITY OF UTAH | 2000 CIRCLE OF HOPE | 2000 CIRCLE OF HOPE | SALT LAKE CITY | UT | 84112 | 876000525 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF UTAH | ||||||||||
| UNIVERSITY OF UTAH | 2000 CIRCLE OF HOPE | 2000 CIRCLE OF HOPE | SALT LAKE CITY | UT | 84112 | 876000525 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| VIRGINIA COMMONWEALTH UNIVERSITY | ||||||||||
| VIRGINIA COMMONWEALTH UNIVERSITY | 401 COLLEGE STREET | 401 COLLEGE STREET | RICHMOND | VA | 23298 | 546001758 | 3 | 200000 | ACCRUAL | RESEARCH GRANT |
| FRED HUTCHINSON CANCER RESEARCH CEN | ||||||||||
| FRED HUTCHINSON CANCER RESEARCH CEN | 1100 FAIRVIEW AVENUE NORTH | 1100 FAIRVIEW AVENUE NORTH | SEATTLE | WA | 98109 | 237156071 | 3 | 1250000 | ACCRUAL | RESEARCH GRANT |
| FRED HUTCHINSON CANCER RESEARCH CEN | ||||||||||
| FRED HUTCHINSON CANCER RESEARCH CEN | 1100 FAIRVIEW AVENUE NORTH | 1100 FAIRVIEW AVENUE NORTH | SEATTLE | WA | 98109 | 237156071 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| FRED HUTCHINSON CANCER RESEARCH CEN | ||||||||||
| FRED HUTCHINSON CANCER RESEARCH CEN | 1100 FAIRVIEW AVENUE NORTH | 1100 FAIRVIEW AVENUE NORTH | SEATTLE | WA | 98109 | 237156071 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| FRED HUTCHINSON CANCER RESEARCH CEN | ||||||||||
| FRED HUTCHINSON CANCER RESEARCH CEN | 1100 FAIRVIEW AVENUE NORTH | 1100 FAIRVIEW AVENUE NORTH | SEATTLE | WA | 98109 | 237156071 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF WASHINGTON | ||||||||||
| UNIVERSITY OF WASHINGTON | 1100 NE 45TH STREET | 1100 NE 45TH STREET | SEATTLE | WA | 98105 | 916001537 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF WASHINGTON | ||||||||||
| UNIVERSITY OF WASHINGTON | 1100 NE 45TH STREET | 1100 NE 45TH STREET | SEATTLE | WA | 98105 | 916001537 | 3 | 55000 | ACCRUAL | RESEARCH GRANT |
| UNIVERSITY OF WASHINGTON | ||||||||||
| UNIVERSITY OF WASHINGTON | 1100 NE 45TH STREET | 1100 NE 45TH STREET | SEATTLE | WA | 98105 | 916001537 | 3 | 65000 | ACCRUAL | RESEARCH GRANT |
| BLOOD RESEARCH INSTITUTE BLOOD CE | ||||||||||
| BLOOD RESEARCH INSTITUTE BLOOD CE | 8727 W WATERTOWN PLANK ROAD | 8727 W WATERTOWN PLANK ROAD | MILWAUKEE | WI | 53226 | 390807235 | 3 | 110000 | ACCRUAL | RESEARCH GRANT |
| MEDICAL COLLEGE OF WISCONSIN | ||||||||||
| MEDICAL COLLEGE OF WISCONSIN | 8701 WATERTOWN PLANK ROAD | 8701 WATERTOWN PLANK ROAD | MILWAUKEE | WI | 53226 | 3 | 110000 | ACCRUAL | RESEARCH GRANT | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Nbr Of501 C3 And Govt Grants | 266 | TotalNbrOf501C3AndGovtGrants |
| Total Nbr Of Other Organizations | 12 | TotalNbrOfOtherOrganizations |
Form990 Schedule I Part III Form990ScheduleIPartIII (6 entries)
| Type Of GrantTypeOfGrant | Number Of RecipientsNumberOfRecipients | Amount Of Cash GrantAmountOfCashGrant |
|---|---|---|
| PATIENT AID | 37210 | 5579396 |
| CO-PAY ASSISTANCE-CML | 1126 | 3870000 |
| CO-PAY ASSISTANCE-CLL | 1468 | 5040000 |
| CO-PAY ASSISTANCE-LYMPHOM | 5611 | 14367178 |
| CO-PAY ASSISTANCE-MDS | 1041 | 2789737 |
| CO-PAY ASSISTANCE-MYELOMA | 3884 | 11880000 |
Form990 Schedule I Part IV Form990ScheduleIPartIV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | PROCEDURES FOR MONITORING THE USE OF GRANT FUNDS INSIDE THE UNITED STATES | Identifier |
| Return Reference | SCHEDULE I, PAGE 1, PART I, LINE 2 | ReturnReference |
| Explanation | FIDUCIARY RESPONSIBILITY AND TRANSPARENCY TO OUR DONORS IS A HIGH PRIORITY. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) PLACES CONSIDERABLE EMPHASIS ON THE OVERSIGHT OF GRANT SPENDING. TO ACCOMPLISH THIS WE REQUIRE THE SUBMISSION OF ANNUAL FINANCIAL REPORTS FOR EACH OF OUR ACTIVE GRANTS. THE REPORT MUST BE SIGNED BY THE FINANCIAL OFFICER AND/OR THE DESIGNATED OFFICIAL OF THE INSTITUTION HOSTING THE AWARD. AT THE END OF THE GRANT, WE REQUIRE A FINAL FINANCIAL REPORT THAT PROVIDES AN OVERVIEW OF ALL SPENDING THROUGH THE DURATION OF THE AWARD.WE REQUIRE SPECIFIC ACCOUNTING OF SPENDING ON PERSONNEL, CONSULTANTS,EQUIPMENT PURCHASES, SUPPLIES, TRAVEL, PATIENT CARE COSTS, ANIMAL CARE COSTS, AND ANY OTHER EXPENSE A GRANTEE MAY INCUR. WE HAVE SPECIFIC INSTRUCTIONS AND DOLLAR AMOUNT LIMITATIONS SET FOR MANY OF THESE CATEGORIES DEPENDING ON THE AWARD TYPE. FINANCIAL REPORTS ARE REVIEWED FOR NUMERICAL ACCURACY, ADHERENCE TO OUR GUIDELINES, AND FOR THE VERIFICATION OF APPROVAL FROM THE INSTITUTION'S FINANCIAL OFFICER. IF THE GRANTEE DOES NOT SUBMIT AN ANNUAL FINANCIAL REPORT BY THE DUE DATE OUTLINED IN THEIR CONTRACT, FUNDING IS SUSPENDED UNTIL LLS RECEIVES AND APPROVES THE DELINQUENT REPORT. | Explanation |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | X | CompensationCommittee |
| Independent Consultant | X | IndependentConsultant |
| Form990 Of Other Organizations | X | Form990OfOtherOrganizations |
| Compensation Survey | X | CompensationSurvey |
| Board Or Committee Approval | X | BoardOrCommitteeApproval |
| Severance Payment | false | SeverancePayment |
| Supplemental Nonqual Retire Plan | false | SupplementalNonqualRetirePlan |
| Equity Based Comp Arrangement | false | EquityBasedCompArrangement |
| Comp Based On Revenue Of Filing Org | false | CompBasedOnRevenueOfFilingOrg |
| Comp Based On Revenue Related Orgs | false | CompBasedOnRevenueRelatedOrgs |
| Comp Based Net Earnings Filing Org | false | CompBasedNetEarningsFilingOrg |
| Comp Based Net Earnings Relate Orgs | false | CompBasedNetEarningsRelateOrgs |
| Any Non Fixed Payments | true | AnyNonFixedPayments |
| Initial Contract Exception | false | InitialContractException |
Form990 Schedule J Part II Form990ScheduleJPartII (7 entries)
| Base Compensation Filing OrgBaseCompensationFilingOrg | Bonus Filing OrgBonusFilingOrg | Other Compensation Filing OrgOtherCompensationFilingOrg | Deferred Comp Filing OrgDeferredCompFilingOrg | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrg | Total Compensation Filing OrgTotalCompensationFilingOrg |
|---|---|---|---|---|---|
| JOHN WALTER | |||||
| 475000 | 38000 | 6525 | 30870 | 21623 | 572018 |
| JAMES T NANGLE | |||||
| 212292 | 10549 | 9975 | 22284 | 21623 | 276723 |
| LOUIS DEGENNARO | |||||
| 315217 | 22050 | 8789 | 24500 | 14609 | 385165 |
| NANCY KLEIN | |||||
| 315051 | 12600 | 9919 | 24500 | 21623 | 383693 |
| DAVID TIMKO | |||||
| 230830 | 4568 | 12066 | 23451 | 14609 | 285524 |
| MICHAEL OSSO | |||||
| 210769 | 9215 | 10537 | 14911 | 14603 | 260035 |
| GEORGE OMIROS | |||||
| 205904 | 4093 | 9959 | 21000 | 14609 | 255565 |
Form990 Schedule J Part III Form990ScheduleJPartIII
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | NON-FIXED PAYMENTS PROVIDED | Identifier |
| Return Reference | SCHEDULE J, PAGE 1, PART I, LINE 7 | ReturnReference |
| Explanation | BONUSES WERE PAID BASED ON THE ACHIEVEMENT OF GROSS REVENUE EXCEEDING BUDGETED GROSS REVENUE,EMPLOYEE INDIVIDUAL PERFORMANCE AND OTHER METRICS. BONUSES WERE CAPPED ACCORDING TO LLS'S POLICY. | Explanation |
Schedule L IRS990ScheduleL
Form990 Schedule L Part IV Form990ScheduleLPartIV
Name Of Interested Person NameOfInterestedPerson
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Person | JAMES DAVIS | NamePerson |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Relationship | BOD MEMBER | Relationship |
| Amount Of Transaction | 307026 | AmountOfTransaction |
| Description Of Transaction | EQUITY IN AEGERA | DescriptionOfTransaction |
| Sharing Of Revenues | false | SharingOfRevenues |
Form990 Schedule L Part V Form990ScheduleLPartV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | ADDITIONAL INFORMATION | Identifier |
| Return Reference | SCHEDULE L PART V | ReturnReference |
| Explanation | PART IV LINE 1 JAMES DAVIS IS AN EXECUTIVE OFFICER WITH HUMAN GENOME SCIENCES WHICH HAS AN EQUITY STAKE IN AEGERA THERAPEUTICS A RECIPIENT OF A THERAPY ACCELERATION PROJECT CONTRACT | Explanation |
Schedule M IRS990ScheduleM
Securities Publicly Traded SecuritiesPubliclyTraded
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | X | NonCashCheckbox |
| Number Of Contributions | 88 | NumberOfContributions |
| Noncash Contribs Rptd F990 | 962451 | NoncashContribsRptdF990 |
| Method Of Determining Revenues | MARKET VALUE | MethodOfDeterminingRevenues |
Food Inventory FoodInventory
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | X | NonCashCheckbox |
| Number Of Contributions | 34 | NumberOfContributions |
Other Non Cash Contributions Table OtherNonCashContributionsTable (3 entries)
| Non Cash CheckboxNonCashCheckbox | DescriptionDescription | Number Of ContributionsNumberOfContributions |
|---|---|---|
| X | PRINTED ITEMS | 3 |
| X | FURNITURE&EQUIP | 5 |
| X | VARIOUS OTHERS | 39 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeld |
| Review Process Unusual NC Gifts | true | ReviewProcessUnusualNCGifts |
| Third Parties Used | true | ThirdPartiesUsed |
Form990 Schedule M Part II Form990ScheduleMPartII (3 entries)
| IdentifierIdentifier | Return ReferenceReturnReference | ExplanationExplanation |
|---|---|---|
| THIRD PARTY USED TO PROCESS NONCASH CONTRIBUTIONS | SCHEDULE M, PAGE 1, PART I, LINE 32B | LLS USES ITS INVESTMENT CUSTODIAN TO LIQUIDATE ANY DONATED SECURITIES. |
| EXPLANATION FOR NOT REPORTING REVENUE | SCHEDULE M, PAGE 1, PART I, LINE 33 | LLS ONLY RECORDS DONATED SECURITIES AS REVENUE. ALL OTHER ITEMS FOR WHICH COLUMN A IS CHECKED ARE NOT RECORDED AS REVENUE OR EXPENSE BECAUSE THEY WOULD NOT HAVE BEEN PURCHASED HAD THEY NOT BEEN DONATED, AND ARE IMMATERIAL IN AMOUNT RELATIVE TO THE STATEMENTS OF LLS. |
| SUPPLEMENTAL INFORMATION | SCHEDULE M, PAGE 2, PART II | PART I, COLUMN (B) LLS IS REPORTING THE NUMBER OF CONTRIBUTIONS FOR EACH OF THE ITEMS IN PART I, NOT THE NUMBER OF INDIVIDUAL ITEMS. |
Schedule O IRS990ScheduleO
General Explanation GeneralExplanation (16 entries)
| IdentifierIdentifier | Return ReferenceReturnReference | ExplanationExplanation |
|---|---|---|
| FIRST ACHIEVEMENT DESCRIPTION | FORM 990, PAGE 2, PART III, LINE 4A | TO DATE, LLS HAS INVESTED MORE THAN 814 MILLION IN RESEARCH AIMED AT HELPING ALL BLOOD CANCER PATIENTS LIVE BETTER, LONGER LIVES. WE WILL CONTINUE TO SUPPORT RESEARCH THROUGH OUR INNOVATIVE AND INTEGRATED FUNDING PROGRAMS, UNTIL EVERY PATIENT HAS A SAFE AND EFFECTIVE THERAPY. IN FISCAL YEAR 2011, LLS SUPPORTED RESEARCH IN THE U.S., CANADA, AND 10 OTHER COUNTRIES WITH A TOTAL RESEARCH DISBURSEMENT OF MORE THAN 66 MILLION. OUR CRITICAL ROLE LLS PROGRAMS ACCELERATE RELEVANT RESEARCH OUTCOMES BY: -BUILDING A FOCUSED RESEARCH WORK-FORCE: ASSURING THE NEXT ROUND OF BREAKTHROUGHS REQUIRES THAT YOUNG INVESTIGATORS BE ENCOURAGED TO WORK IN BLOOD CANCER RESEARCH FIELDS. -TURNING DISCOVERIES INTO CLINICAL PROGRESS: BASIC SCIENCE DISCOVERIES MUST BE TRANSLATED INTO NEW, SAFE AND EFFECTIVE TREATMENTS THAT CAN ULTIMATELY PROLONG AND ENHANCE PATIENT LIVES. -SUPPORTING SYNERGY: LARGE GRANTS AND CONTRACTS ENABLE SCIENTISTS IN ACADEMIA AND THE PRIVATE-SECTOR TO COLLABORATE, COMBINING RESOURCES AND EXPERTISE TO PRODUCE MORE AND FASTER ADVANCES. -FILLING A VOID: PROMISING RESEARCH PROJECTS THAT ARE HIGH-RISK AND/OR ADDRESS RARE CANCERS ARE LESS LIKELY TO BE FUNDED BY THE GOVERNMENT OR BY FOR-PROFIT COMPANIES, BUT MAY PROVIDE IMPORTANT ADVANCES. -INCREASING ACCESS TO CLINICAL TRIALS: PARTNERING WITH LEADING CLINICAL TRIAL CENTERS CAN ACCELERATE THE CLINICAL TESTING OF NEW BLOOD CANCER THERAPIES THAT ARE OFTEN A PATIENT'S BEST CHANCE FOR CURE. LLS RESEARCH PROGRAMS ARE BASED ON THE BELIEF THAT SCIENTIFICALLY SOUND APPROACHES TOWARD CURES FOR, OR CONTROL OF, BLOOD CANCERS SHOULD BE SUPPORTED WORLDWIDE.TWO MAJOR INTEGRATED RESEARCH FUNDING PROGRAMS THE RESEARCH GRANT PROGRAM AND THE THERAPY ACCELERATION PROGRAM HAVE ADVISORY INPUT FROM WORLD RENOWNED BIOMEDICAL RESEARCH EXPERTS. TOGETHER THESE PROGRAMS: -SUPPORT THE ENTIRE RESEARCH CONTINUUM NEEDED TO IMPROVE OUTCOMES FOR BLOOD CANCER PATIENTS FROM BASIC LABORATORY SCIENCE TO CLINICAL TRIALS OF NEW AGENTS AND FROM INVESTIGATOR INITIATED RESEARCH TO MULTIDISCIPLINARY ACADEMIC COLLABORATIONS AND PRIVATE SECTOR DRUG DEVELOPMENT ALLIANCES. -ARE AIMED AT THE EFFECTIVE DISCOVERY AND DEVELOPMENT OF NEW AND BETTER THERAPIES FOR PEOPLE WITH BLOOD CANCER, AND, THROUGH A RESEARCH INITIATIVE LAUNCHED IN 2009, SUPPORT THE DEVELOPMENT OF MEASURES TO PREVENT OR SIGNIFICANTLY REDUCE POTENTIAL LONG-TERM AND LATE TOXICITIES OF TODAY'S CURATIVE THERAPIES. RESEARCH GRANT PROGRAM THE RESEARCH GRANT PROGRAM PROVIDES GRANT FUNDING TO SUPPORT SCIENTIFIC STUDIES AT ACADEMIC CENTERS IN THE UNITED STATES AND THROUGHOUT THE WORLD, THROUGH THREE GRANT MECHANISMS: 1. THE CAREER DEVELOPMENT PROGRAM (CDP) PROVIDES STIPENDS TO INVESTIGATORS OF EXCEPTIONAL PROMISE IN THE EARLY STAGES OF THEIR CAREERS, HELPING THEM TO DEVOTE THEIR CAREERS TO LEUKEMIA, LYMPHOMA AND/OR MYELOMA RESEARCH. THIS PROGRAM IS STRATIFIED INTO TWO SEPARATELY REVIEWED PROGRAMS IN BASIC OR CLINICAL RESEARCH: -BASIC RESEARCH "SCHOLARS ARE AWARDED UP TO 110,000 A YEAR FOR A TOTAL OF UP TO 550,000 OVER FIVE YEARS. "SPECIAL FELLOWS ARE AWARDED UP TO 65,000 A YEAR FOR A TOTAL OF UP TO 195,000 OVER THREE YEARS. "FELLOWS ARE AWARDED UP TO 55,000 A YEAR FOR A TOTAL OF UP TO 165,000 OVER THREE YEARS. -CLINICAL RESEARCH "SCHOLARS IN CLINICAL RESEARCH ARE AWARDED UP TO 110,000 A YEAR FOR A TOTAL OF UP TO 550,000 OVER FIVE YEARS. "SPECIAL FELLOWS IN CLINICAL RESEARCH ARE AWARDED UP TO 65,000 A YEAR FOR A TOTAL OF UP TO 195,000 OVER THREE YEARS. 2. THE TRANSLATIONAL RESEARCH PROGRAM (TRP) SUPPORTS OUTSTANDING INVESTIGATIONS DEEMED BY OUR EXPERT ADVISORS MOST LIKELY TO TRANSLATE BASIC BIOMEDICAL DISCOVERIES INTO NEW, SAFE AND EFFECTIVE TREATMENTS, ULTIMATELY PROLONGING AND ENHANCING PATIENTS' LIVES. TRANSLATIONAL RESEARCH AWARDS ARE MADE FOR AN INITIAL THREE-YEAR PERIOD. AWARDS UP TO 200,000 PER YEAR FOR THREE YEARS, FOR A TOTAL OF UP TO 600,000, ARE GRANTED EACH YEAR. FUNDING FOR TWO ADDITIONAL YEARS MAY BE PROVIDED FOR HIGHLY PROMISING PROJECTS THAT ARE ENTERING PHASE 1 CLINICAL TRIALS. THUS, RESEARCH REACHING A CLINICAL TRIAL CAN RECEIVE UP TO 1 MILLION OVER FIVE YEARS TO FACILITATE NEW DRUG DISCOVERY OR ADVANCES IN DIAGNOSIS OR PREVENTION. IN 2011, LLS ACTIVELY REQUESTED PROPOSALS TO HELP STIMULATE MORE ACADEMIC RESEARCH IN THREE UNDERDEVELOPED YET IMPORTANT AREAS OF RESEARCH. THE RESEARCH TOPICS EMPHASIZED WERE: 1) THE MALIGNANT STEM CELL IN ACUTE MYELOGENOUS LEUKEMIA AND MYELODYSPLASTIC SYNDROMES; 2) NON-CUTANEOUS T-CELL LEUKEMIAS AND LYMPHOMAS AND 3) HIGH RISK MYELOMA CASES. IN ADDITION, A REQUEST FOR RESEARCH FOCUSED ON LONG-TERM AND LATE EFFECTS OF BLOOD CANCER THERAPIES WAS EXTENDED INTO A SECOND YEAR. PROGRESS IN THESE RESEARCH AREAS IS DEEMED LIKELY TO IMPROVE OUTCOMES FOR PATIENTS WITH PARTICULARLY URGENT NEEDS. 3. THE MARSHALL A. LICHTMAN SPECIALIZED CENTER OF RESEARCH PROGRAM (SCOR) ENCOURAGES MULTIDISCIPLINARY RESEARCH BY LEADING-EDGE ACADEMIC INVESTIGATORS IN TEAMS OF AT LEAST THREE RESEARCH GROUPS THAT INTERACT TO FOSTER ADVANCES IN THE DIAGNOSIS, TREATMENT AND/OR PREVENTION OF BLOOD CANCERS. EACH SCOR GROUP IS FUNDED UP TO 1.25 MILLION PER YEAR OVER A FIVE-YEAR PERIOD, WITH A TOTAL AMOUNT OF UP TO 6.25 MILLION. AWARDS GO TO THOSE GROUPS THAT BEST DEMONSTRATE SYNERGISTIC EXPERTISE IN COMPLEMENTARY AREAS . THE PARTICIPATING SCIENTISTS MAY BE AT DIFFERENT INSTITUTIONS OR FROM ANY COUNTRY. THE GRANT REVIEW PROCESS FOR THE RESEARCH GRANT PROGRAM. SCIENTISTS AND PHYSICIAN SCIENTISTS WHO ARE EXPERTS IN THE FIELD OF BLOOD CANCER RESEARCH VOLUNTEER THEIR SERVICE TO CONSTITUTE PEER-REVIEW SUBCOMMITTEES FOR BASIC RESEARCH CDP, CLINICAL RESEARCH CDP, TRP AND SCOR. THESE COMMITTEES EVALUATE ALL GRANT APPLICATIONS IN THOSE PROGRAMS AND SELECT THOSE APPLICANTS WITH THE MOST INNOVATIVE AND IMPORTANT PROJECTS TO ADVANCE THE MISSION OF LLS. GUIDELINES, INSTRUCTIONS AND APPLICATIONS FOR THE THREE LLS RESEARCH PROGRAMS MAY BE OBTAINED BY VISITING WWW.LLS.ORG OR BY EMAILING RESEARCHPROGRAMS@LLS.ORG. THERAPY ACCELERATION PROGRAM THE THERAPY ACCELERATION PROGRAM (TAP) IS A STRATEGIC LLS INITIATIVE LAUNCHED IN 2007 WITH 4 MILLION IN SEED FUNDING. THE PROGRAM ACCELERATES NEW AND POTENTIALLY BETTER TREATMENTS AND CLINICAL TESTS INTO PRECLINICAL DEVELOPMENT AND CLINICAL TRIALS. WORKING IN CONCERT WITH ACADEMIC INVESTIGATORS, MEDICAL CENTERS AND COMPANIES, TAP IS FURTHER BRIDGING THE GAP BETWEEN DISCOVERY AND HUMAN APPLICATIONS TO INCREASE THE LIKELIHOOD THAT NOVEL, POSSIBLY BREAKTHROUGH, TREATMENTS WILL BE MADE AVAILABLE TO PATIENTS AS SOON AS POSSIBLE. TAP ENCOMPASSES THREE INNOVATIVE EFFORTS: 1. THE ACADEMIC CONCIERGE DIVISION IDENTIFIES CURRENT LLS FUNDED RESEARCH WITH THE GREATEST CLINICAL PROMISE AND PROVIDES THE FUNDING AND SUPPORT NEEDED TO ADVANCE SELECTED PROJECTS TO THE PRODUCT STAGE. 2.THE CLINICAL TRIALS DIVISION PARTNERS LLS WITH ONE OF THE COUNTRY'S LEADING CLINICAL TRIAL CENTERS TO ACCELERATE THE TESTING OF NEW BLOOD CANCER THERAPIES IN CLINICAL TRIALS. 3. THE BIOTECHNOLOGY ACCELERATOR DIVISION ALLIES LLS WITH COMPANIES TO COMBINE SCIENTIFIC AND FINANCIAL RESOURCES AND ACCELERATE THE DEVELOPMENT OF POTENTIAL THERAPIES THAT OTHERWISE WOULD NOT BE PRIORITIZED BY THE COMPANY. THE TAP PROJECT REVIEW PROCESS INVOLVES DUE DILIGENCE BY AN LLS STAFF TEAM OF DRUG DEVELOPMENT SPECIALISTS IN CONCERT WITH A VOLUNTEER PANEL OF LEADING BIOTECHNOLOGY AND PHARMACEUTICAL COMPANY EXECUTIVES AND INTELLECTUAL PROPERTY AND BUSINESS DEVELOPMENT EXPERTS. THE LEARNING COLLABORATIVE IN 2011, LLS BEGAN A UNIQUE COLLABORATION WITH THE UNIVERSITY OF KANSAS CANCER CENTER AND THE NATIONAL INSTITUTES OF HEALTH TO ACCELERATE THE DEVELOPMENT OF POTENTIAL THERAPIES FOR RARE BLOOD CANCERS. THIS COLLABORATION, KNOWN AS THE LEARNING COLLABORATIVE, BRINGS TOGETHER PROVEN EXPERTISE IN BLOOD CANCER RESEARCH AS WELL AS DRUG DISCOVERY AND DEVELOPMENT TO RAPIDLY ADVANCE PROMISING NEW THERAPIES FROM THE BENCH TO THE BEDSIDE. IF SUCCESSFUL, THE LEARNING COLLABORATIVE'S NOVEL MODEL WILL DEMONSTRATE THAT GOVERNMENT, ACADEMIA, DISEASE PHILANTHROPY AND INDUSTRY CAN SUCCESSFULLY PARTNER TO SAFELY AND EFFICIENTLY ADVANCE NEW OR REPURPOSED DRUG THERAPIES TO PATIENTS. |
| SECOND ACHIEVEMENT DESCRIPTION | FORM 990, PAGE 2, PART III, LINE 4B | CHAPTER-BASED PROGRAMS: EACH LLS CHAPTER IS STAFFED WITH A PATIENT SERVICES MANAGER WHO OVERSEES THE CHAPTER'S SERVICES TO PATIENTS AND THEIR FAMILIES. PATIENT SERVICES MANAGERS ARE HEALTHCARE PROFESSIONALS, OFTEN WITH A BACKGROUND IN ONCOLOGY NURSING OR SOCIAL WORK. COMMUNITY BASED EDUCATION, INCLUDING THE FOLLOWING FOUR PROGRAMS, ARE OFFERED THROUGH ALL THE CHAPTERS - 38,959 PATIENT AND CAREGIVER PARTICIPANTS IN 2011 - 12,236 HEALTHCARE PROFESSIONAL PARTICIPANTS IN 2011 IMPROVING TREATMENTS FOR BLOOD CANCERS: WHAT YOU NEED TO KNOW TO MAKE INFORMED DECISIONS THIS PROGRAM DETAILS NEW TREATMENT DEVELOPMENT, TREATMENT DECISIONS (STANDARD OF CARE VERSUS CLINICAL TRIALS) AND HOW PATIENTS CAN COMMUNICATE MORE EFFECTIVELY WITH THEIR MEDICAL TEAMS. MYELOMA UPDATE: DIAGNOSIS, TREATMENT AND SIDE EFFECTS MANAGEMENT THIS PROGRAM PROVIDES PATIENTS, FAMILY MEMBERS AND CAREGIVERS WITH THE LATEST INFORMATION ON MYELOMA AND MYELOMA THERAPY, INCLUDING A QUESTION AND ANSWER SESSION WITH A MEDICAL EXPERT IN THEIR COMMUNITY. GETTING THE BEST CANCER CARE AT AGE 55 AND OLDER THIS EDUCATION PROGRAM PRESENTS AN OVERVIEW OF THE MANY FACTORS, NOT AGE ALONE, THAT HEALTHCARE PROFESSIONALS SHOULD ASSESS TO DETERMINE AN APPROPRIATE CANCER TREATMENT PLAN FOR AN OLDER ADULT. WELCOME BACK: WORKING TOGETHER TO SUPPORT THE CANCER SURVIVOR AT SCHOOL THIS EDUCATION PROGRAM DISCUSSES POSSIBLE EMOTIONAL AND COGNITIVE SHORT- AND LONG-TERM EFFECTS THAT CHILDREN MAY EXPERIENCE AFTER TREATMENT, AND OFFERS NUMEROUS RESOURCES THAT CAN IMPROVE THE TRANSITION OF CANCER SURVIVORS FROM CLINIC TO CLASSROOM. SUPPORT SERVICES: FAMILY SUPPORT GROUPS LLS HAS DEVELOPED 452 FAMILY SUPPORT GROUPS AT CHAPTERS THROUGHOUT THE US AND CANADA. LLS ALSO HAS 825 VOLUNTEER SUPPORT GROUP FACILITATORS WITH BACKGROUNDS IN ONCOLOGY NURSING OR SOCIAL WORK. GROUPS ARE GUIDED BY TWO VOLUNTEER ONCOLOGY HEALTH PROFESSIONALS, AND PROVIDE INFORMATION AND SUPPORT AND ENCOURAGE GREATER COMMUNICATION AMONG PATIENTS, FAMILIES, FRIENDS AND HEALTH CARE PROFESSIONALS. - 13,108 PARTICIPANTS IN FAMILY SUPPORT GROUPS IN 2011 PATTI ROBINSON KAUFMANN FIRST CONNECTION PROGRAM FIRST CONNECTION IS A PROGRAM THAT LINKS NEWLY DIAGNOSED PATIENTS TO A PEER VOLUNTEER WHO HAS EXPERIENCED A SIMILAR DIAGNOSIS. A TRAINED PATIENT-VOLUNTEER CURRENTLY IN REMISSION CONTACTS THE NEW PATIENT TO SHARE INFORMATION AND SUPPORT. THIS PROGRAM IS AVAILABLE THROUGH LLS CHAPTERS. - 5,094 FIRST CONNECTIONS IN 2011 PATIENT FINANCIAL AID PROGRAM FOR MORE THAN 45 YEARS, LLS HAS HELPED PATIENTS DEMONSTRATING SIGNIFICANT NEED TO OBTAIN FINANCIAL ASSISTANCE TO COVER A PORTION OF THEIR TREATMENT COSTS. THE LLS PATIENT FINANCIAL AID PROGRAM PROVIDES A LIMITED AMOUNT OF FINANCIAL ASSISTANCE TO HELP PATIENTS WITH SIGNIFICANT FINANCIAL NEED AND WHO ARE UNDER A DOCTOR'S CARE FOR A CONFIRMED BLOOD CANCER DIAGNOSIS. PATIENT FINANCIAL AID FUNDS ARE SUBJECT TO AVAILABILITY. - 37,210 PATIENTS RECEIVED FINANCIAL AID IN 2011 CO-PAY ASSISTANCE PROGRAM THIS ASSISTANCE PROGRAM HELPS PATIENTS WITH MANY KINDS OF BLOOD CANCERS MEET THEIR HEALTH INSURANCE OR MEDICARE PLAN PART B OR D PREMIUMS OR CO-PAYMENT OBLIGATIONS RELATED TO TREATING THEIR CANCER. PATIENTS WITH PRESCRIPTION DRUG COVERAGE, MEDICARE BENEFICIARIES UNDER MEDICARE PART B AND/OR MEDICARE PART D, MEDICARE SUPPLEMENTARY HEALTH INSURANCE OR MEDICARE ADVANTAGE SHOULD CHECK WITH LLS TO SEE IF THEY MEET ELIGIBILITY REQUIREMENTS TO RECEIVE FINANCIAL SUPPORT. CO-PAY ASSISTANCE IS SUBJECT TO FUND AVAILABILITY BY SPECIFIC BLOOD CANCER DIAGNOSIS. FOR MORE INFORMATION CALL, (877) LLS-COPAY (877) 557-2672 OR VISIT WWW.LLS.ORG/COPAY. - 13,130 PATIENTS RECEIVED LLS CO-PAY ASSISTANCE IN 2011 THE TRISH GREENE BACK TO SCHOOL PROGRAM FOR CHILDREN WITH CANCER THIS PROGRAM IS DESIGNED TO INCREASE COMMUNICATION AMONG HEALTH CARE PROFESSIONALS, PARENTS, PATIENTS AND SCHOOL PERSONNEL TO ASSURE YOUNGSTERS A SMOOTH TRANSITION FROM ACTIVE TREATMENT BACK TO SCHOOL. PRINTED LITERATURE, VIDEOS AND OTHER MATERIALS TO AID THE PROCESS ARE AVAILABLE THROUGH ALL LOCAL CHAPTERS, INCLUDING: "WELCOME BACK: WORKING TOGETHER TO SUPPORT THE CANCER SURVIVOR AT SCHOOL". THIS EDUCATION PROGRAM DISCUSSES POSSIBLE EMOTIONAL AND COGNITIVE SHORT- AND LONG-TERM EFFECTS THAT CHILDREN MAY EXPERIENCE AFTER TREATMENT, AND OFFERS NUMEROUS RESOURCES THAT CAN IMPROVE THE TRANSITION OF CANCER SURVIVORS FROM CLINIC TO CLASSROOM. - 3,219 SCHOOL PERSONNEL, HEALTHCARE PROFESSIONALS AND PARENTS PARTICIPATED IN THE 74 WELCOME BACK PROGRAMS ACROSS THE US AND CANADA "LEARNING AND LIVING WITH CANCER: ADVOCATING FOR YOUR CHILD'S EDUCATIONAL NEEDS" THIS BOOKLET OFFERS PARENTS INFORMATION ON THE LEARNING CHALLENGES CHILDREN MAY FACE DURING AND AFTER CANCER TREATMENT, LAWS THAT PROTECT THE EDUCATIONAL NEEDS OF CHILDREN WITH CANCER AND SPECIFIC WAYS THAT SCHOOLS CAN HELP MEET A CHILD'S EDUCATIONAL NEEDS |
| THIRD ACHIEVEMENT DESCRIPTION | FORM 990, PAGE 2, PART III, LINE 4C | PATIENTS, FAMILIES AND HEALTHCARE PROFESSIONALS MAY SPEAK TO AN INFORMATION SPECIALIST AT (800) 955-4572 MONDAY THROUGH FRIDAY, 9 A.M. TO 6 P.M., ET OR EMAIL INFOCENTER@LLS.ORG. - 69,777 INQUIRIES IN 2011 - TRANSLATION SERVICES AVAILABLE IN MORE THAN 165 LANGUAGES ONLINE ENGAGEMENT THE LLS WEBSITE SERVES A WIDE VARIETY OF EDUCATION AND INFORMATION NEEDS. USERS CAN PERSONALIZE THEIR LLS WEB PAGES TO KEEP CURRENT WITH DISEASE SPECIFIC UPDATES AND LOCAL CHAPTER EDUCATION, SUPPORT AND EVENT ACTIVITIES. THE SITE FEATURES A COMPREHENSIVE OVERVIEW OF LLS PROGRAMS AND SERVICES, FAMILY SUPPORT GROUP LOCATIONS, INFORMATION ABOUT OUR PEER-TO-PEER PATTI ROBINSON KAUFMANN FIRST CONNECTION PROGRAM, AND OTHER PROGRAMS. PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS CAN INTERACT WITH LLS IN CONVENIENT AND PERSONAL WAYS THROUGH SOCIAL NETWORKING, PODCASTS AND ENEWSLETTERS. - 5.8 MILLION UNIQUE VISITS TO WWW.LLS.ORG IN 2011, WITH MORE THAN 7.5 MILLION PAGE VIEWS - 409,799 UNIQUE VISITS TO OUR BLOOD CANCER DISCUSSION BOARDS - 157,877 TELECONFERENCE DOWNLOADS - 208,822 SUBSCRIBERS TO OUR DISEASE SPECIFIC ENEWSLETTERS, WHICH ARE ISSUED ON A MONTHLY BASIS - 116,797 FOLLOWERS OF OUR PATIENT AND CAREGIVER COMMUNITY ONLINE TELEPHONE & WEB EDUCATION PROGRAMS LLS SPONSORS TELEPHONE AND WEB EDUCATION PROGRAMS FOR PATIENTS, CAREGIVERS, SURVIVORS AND HEALTHCARE PROFESSIONALS ABOUT LEUKEMIA, LYMPHOMA, MYELOMA AND MYELODYSPLASTIC SYNDROMES. UPCOMING PROGRAMS ARE POSTED AT WWW.LLS.ORG/PROGRAMS AND ARCHIVES OF PAST PROGRAMS ARE AVAILABLE AT WWW.LLS.ORG/PASTPROGRAMS. - 251,077 TELEPHONE AND WEB-BASED PROGRAM PARTICIPANTS IN 2011 EDUCATION MATERIALS AN EXTENSIVE CATALOG OF EDUCATION MATERIALS IS OFFERED FREE-OF-CHARGE TO PATIENTS AND HEALTHCARE PROFESSIONALS. EACH YEAR, LLS DISTRIBUTES BOOKLETS, BROCHURES, FACT SHEETS, EDUCATION PROGRAM TRANSCRIPTS AND DVDS THROUGH THE INFORMATION RESOURCE CENTER AND LOCAL LLS CHAPTERS. - 1,061,018 PRINTED BOOKLETS, BROCHURES, FACT SHEETS, EDUCATION PROGRAM TRANSCRIPTS AND DVDS DISTRIBUTED IN 2011 MANY MATERIALS ARE ALSO AVAILABLE TO VIEW AND DOWNLOAD AT WWW.LLS.ORG/RESOURCECENTER. DOWNLOADABLE MATERIALS ARE AVAILABLE IN ENGLISH, SPANISH AND FRENCH. |
| ALL OTHER ACHIEVEMENTS DESCRIPTION | FORM 990, PAGE 2, PART III, LINE 4D | D) PROFESSIONAL EDUCATION: LLS SERVES THE EDUCATIONAL NEEDS OF THE MEDICAL AND RESEARCH COMMUNITY THROUGH A NUMBER OF PROFESSIONAL EDUCATION SYMPOSIA OFFERED THROUGHOUT THE YEAR. THE EDUCATIONAL PROGRAM OFFERS VARYING FORMATS TO FACILITATE THE EXCHANGE OF INFORMATION AND IDEAS ON THE NEWEST DEVELOPMENTS IN CANCER RESEARCH AND TREATMENT. |
| FINANCIAL ACCOUNTS IN FOREIGN COUNTRIES | FORM 990, PART V, LINE 4B | CANADA |
| CLASSES OF MEMBERS OR STOCKHOLDERS | FORM 990, PAGE 6, PART VI, LINE 6 | THE MEMBERS OF LLS CONSIST OF ONE ELECTED REPRESENTATIVE FROM EACH CHAPTER. |
| ELECTION OF MEMBERS AND THEIR RIGHTS | FORM 990, PAGE 6, PART VI, LINE 7A | THE BOARD OF REPRESENTATIVES (REPRESENTING THE CHAPTERS) ELECTS THE MEMBERS OF LLS'S GOVERNING BODY, ITS NATIONAL BOARD OF DIRECTORS. |
| DECISIONS SUBJECT TO APPROVAL OF MEMBERS | FORM 990, PAGE 6, PART VI, LINE 7B | SIGNIFICANT DECISIONS AFFECTING THE CHAPTERS REQUIRE AN APPROVING VOTE BY THE CHAPTER DELEGATES. DECISIONS NOT SIGNIFICANTLY AFFECTING THE CHAPTERS DO NOT REQUIRE APPROVAL FROM THE CHAPTER DELEGATES. |
| ORGANIZATION'S PROCESS USED TO REVIEW FORM 990 | FORM 990, PAGE 6, PART VI, LINE 11B | THE FORM 990 WAS PREPARED BY THE LLS FINANCE DEPARTMENT AND WAS REVIEWED BY THE CFO, VICE PRESIDENT OF FINANCE, AND KPMG FOR COMMENT AND SUGGESTED REVISIONS. THE FORM 990 WAS THEN PROVIDED TO THE AUDIT COMMITTEE, WHICH IS A COMMITTEE OF THE BOARD OF DIRECTORS. THE AUDIT COMMITTEE REVIEWED THE 990 AND PROVIDED INPUT PRIOR TO FILING. THE FINAL DRAFT FORM 990 WAS PROVIDED TO THE ENTIRE BOARD OF DIRECTORS PRIOR TO FILING BY POSTING THE FORM ON AN INTRANET WEBSITE. |
| ENFORCEMENT OF CONFLICTS POLICY | FORM 990, PAGE 6, PART VI, LINE 12C | ALL EMPLOYEES, BOARD OF DIRECTORS MEMBERS, BOARD OF REPRESENTATIVES MEMBERS, CHAPTER BOARD MEMBERS, FAMILY SUPPORT GROUP FACILITATORS, AND TNT COACHES ARE REQUIRED TO REVIEW THE CONFLICT OF INTEREST POLICY ON AN ANNUAL BASIS AND SUBMIT A SIGNED FORM ACKNOWLEDGING THAT THEY HAVE REVIEWED THE POLICY AND DISCLOSED ANY CONFLICTS OF INTEREST. ALL FORMS ARE COLLECTED AND THE AUDIT COMMITTEE REVIEWS ANY FORMS DISCLOSING A POSSIBLE CONFLICT OF INTEREST AND DETERMINES WHETHER OR NOT A CONFLICT EXISTS. |
| COMPENSATION PROCESS FOR TOP OFFICIAL | FORM 990, PAGE 6, PART VI, LINE 15A | THE EXECUTIVE COMMITTEE, COMPRISED OF INDEPENDENT MEMBERS OF THE BOARD OF DIRECTORS, REVIEWS AND MONITORS THE CHIEF EXECUTIVE OFFICER'S PERFORMANCE AND COMPENSATION. THE COMMITTEE OBTAINED A SURVEY OF OTHER NOT-FOR-PROFIT ORGANIZATIONS' COMPENSATION RANGES AND SET THE CHIEF EXECUTIVE'S SALARY COMMENSURATELY. THE REVIEW WAS DOCUMENTED IN THE EXECUTIVE COMMITTEE'S MINUTES. |
| COMPENSATION PROCESS FOR OFFICERS | FORM 990, PAGE 6, PART VI, LINE 15B | THE EXECUTIVE COMMITTEE, COMPRISED OF INDEPENDENT MEMBERS OF THE BOARD OF DIRECTORS, REVIEWED A SURVEY OF OTHER NOT-FOR-PROFIT ORGANIZATIONS' COMPENSATION RANGES AND COMPARED THIS TO THE OTHER OFFICER'S SALARY AND DETERMINED THAT IT WAS APPROPRIATE. THE REVIEW WAS DOCUMENTED IN THE EXECUTIVE COMMITTEE'S MINUTES. |
| STATES WHERE COPY OF RETURN IS FILED | FORM 990, PAGE 6, PART VI, LINE 17 | ALASKA, ARKANSAS, ARIZONA, CALIFORNIA, CONNECTICUT, DELAWARE, FLORIDA, GEORGIA, ILLINOIS, INDIANA, KANSAS, KENTUCKY, LOUISIANA, MASSACHUSETTS, MARYLAND, MAINE, MICHIGAN, MINNESOTA, MISSOURI, MISSISSIPPI, NEW HAMPSHIRE, NEW JERSEY, NEW MEXICO, NEVADA, NEW YORK, OHIO, OKLAHOMA, OREGON, PENNSYLVANIA, PUERTO RICO, RHODE ISLAND, SOUTH CAROLINA, TENNESSEE, UTAH, VIRGINIA, WASHINGTON, WISCONSIN, WEST VIRGINIA |
| GOVERNING DOCUMENTS DISCLOSURE EXPLANATION | FORM 990, PAGE 6, PART VI, LINE 19 | THE LEUKEMIA & LYMPHOMA SOCIETY, INC. MAKES ITS ANNUAL FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC ON ITS WEBSITE AT WWW.LLS.ORG. ITS GOVERNING DOCUMENTS ARE MADE AVAILABLE, WHEN CHANGES ARE MADE, AS PART OF THE 990 AVAILABLE FOR PUBLIC INSPECTION. ANY IDENTIFIED CONFLICTS OF INTEREST ARE DISCLOSED IN THE 990. |
| ADDITIONAL INFORMATION | FORM 990, PART VII | SECTION B, LINE 1 |
| OTHER CHANGES IN NET ASSETS EXPLANATION | FORM 990, PART XI, LINE 5 | RECONCILIATION OF CHANGE IN NET ASSETS ON A CONSOLIDATED BASIS TO SEPARATE COMPANY BASIS: CHANGE IN NET ASSETS PER AUDITED FINANCIAL STATEMENTS 10,432,000 PLUS: CHANGE IN NET ASSETS LLS CANADA 183,453 PLUS: LLSRF AND LLSRP ACTIVITY 39,395 PLUS: FOREIGN CURRENCY TRANSLATION ADJUSTMENT (320,000) PLUS: AUDITED FINANCIAL STATEMENT ROUNDING 1,976 EQUALS: CHANGE IN NET ASSETS PER 990 10,336,824 SCHEDULE D PART XI LINE 9 7,440,623 CHANGE IN NET ASSETS ABOVE (95,176) 990 PART XI LINE 5 7,345,447 THE AUDITED FINANCIAL STATEMENTS FOR THE LEUKEMIA & LYMPHOMA SOCIETY, INC. INCLUDE THE LEUKEMIA & LYMPHOMA SOCIETY OF CANADA, THE LEUKEMIA & LYMPHOMA SOCIETY RESEARCH PROGRAMS, INC., AND THE LEUKEMIA & LYMPHOMA SOCIETY RESEARCH FOUNDATION IN ADDITION TO LLS. |
Schedule R IRS990ScheduleR
Form990 Schedule R Part II Form990ScheduleRPartII (3 entries)
| Address Line1AddressForeign/AddressLine1 | CityAddressForeign/City | CountryAddressForeign/Country | Postal CodeAddressForeign/PostalCode | Primary ActivitiesPrimaryActivities | Legal Domicile Foreign CountryLegalDomicileForeignCountry | Direct Controlling Entity NADirectControllingEntityNA | Controlled OrgControlledOrg | Address Line1AddressUS/AddressLine1 | CityAddressUS/City | StateAddressUS/State | ZIP CodeAddressUS/ZIPCode | EINEIN | Legal Domicile StateLegalDomicileState | Exempt Code SectionExemptCodeSection | Public Charity StatusPublicCharityStatus | Business Name Line1DirectControllingEntityName/BusinessNameLine1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| THE LLS OF CANADA | ||||||||||||||||
| 804-2 LANSING SQUARE | TORONTO | CA | M2J4P8 | PART VII | CA | N/A | false | |||||||||
| THE LLS RESEARCH PROGRAMS INC | ||||||||||||||||
| PART VII | true | 1311 MAMARONECK AVENUE | WHITE PLAINS | NY | 10605 | 133470494 | DE | 501C3 | 11B | LLS INC | ||||||
| THE LLS RESEARCH FOUNDATION | ||||||||||||||||
| PART VII | true | 1311 MAMARONECK AVENUE | WHITE PLAINS | NY | 10605 | 133709252 | DE | 501C3 | 11B | LLS INC | ||||||
Form990 Schedule R Part IV Form990ScheduleRPartIV
Name Of Related Org NameOfRelatedOrg
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | ROY & ANN BERGER | BusinessNameLine1 |
Address US AddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 201 LINCOLN AVENUE | AddressLine1 |
| City | NORWELL | City |
| State | MA | State |
| ZIP Code | 02061 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 999999999 | EIN |
| Primary Activity | CRUT | PrimaryActivity |
| Legal Domicile State | NH | LegalDomicileState |
| Direct Controlling Entity NA | N/A | DirectControllingEntityNA |
| Type Of Entity | TRUST | TypeOfEntity |
| Share Of Total Income | 53892 | ShareOfTotalIncome |
| Percentage Ownership | 1.00000 | PercentageOwnership |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Ann Rents Royalties | false | ReceiptOfIntAnnRentsRoyalties |
| Gift Grant Or Cap Contr To Other Org | false | GiftGrantOrCapContrToOtherOrg |
| Gift Grant Or Cap Contr Fr Other Org | true | GiftGrantOrCapContrFrOtherOrg |
| Loans Or Guarantees To Other Org | true | LoansOrGuaranteesToOtherOrg |
| Loans Or Guarantees From Other Org | false | LoansOrGuaranteesFromOtherOrg |
| Sale Of Assets To Other Org | false | SaleOfAssetsToOtherOrg |
| Purchase Of Assets From Other Org | false | PurchaseOfAssetsFromOtherOrg |
| Exchange Of Assets | false | ExchangeOfAssets |
| Rental Of Facilities To Other Orgs | false | RentalOfFacilitiesToOtherOrgs |
| Rental Of Facilities Fr Other Orgs | false | RentalOfFacilitiesFrOtherOrgs |
| Perform Of Services For Other Orgs | false | PerformOfServicesForOtherOrgs |
| Perform Of Services By Other Orgs | false | PerformOfServicesByOtherOrgs |
| Sharing Of Facilities | true | SharingOfFacilities |
| Sharing Of Paid Employees | true | SharingOfPaidEmployees |
| Reimbursement Paid To Other Org | false | ReimbursementPaidToOtherOrg |
| Reimbursement Paid By Other Org | false | ReimbursementPaidByOtherOrg |
| Other Transfer To Other Org | false | OtherTransferToOtherOrg |
| Other Transfer From Other Org | false | OtherTransferFromOtherOrg |
Transactions Related Orgs Table TransactionsRelatedOrgsTable (2 entries)
| Transaction TypeTransactionType | Amount InvolvedAmountInvolved | Method Of Amt DeterminationMethodOfAmtDetermination |
|---|---|---|
| THE LEUKEMIA & LYMPHOMA SOCIETY | ||
| D | 135950 | COST |
| OF CANADA | ||
Form990 Schedule R Part VII Form990ScheduleRPartVII
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | GROUP EXEMPTION RELATIONSHIPS | Identifier |
| Return Reference | SCHEDULE R | ReturnReference |
| Explanation | SCHEDULE R PART II COLUMN B THE LEUKEMIA LYMPHOMA SOCIETY OF CANADA CARRIES OUT THE SAME PRIMARY ACTIVITIES AS THE LEUKEMIA LYMPHOMA SOCIETYINC IN CANADA THE LEUKEMIA LYMPHOMA SOCIETY RESEARCH PROGRAMSINC AND THE LEUKEMIA LYMPHOMA SOCIETY RESEARCH FOUNDATION SUPPORT THE ACTIVITIES OF THE LEUKEMIA LYMPHOMA SOCIETY INC | Explanation |
Comments